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SUMMARY 
in this thesis, the work undertaken in an attempt to gain insight 
into the catalytic function ofneuraminidase is described. 
The history, properties and importance of neuram in idases are 
reviewed in Chapter One. Chapter Two contains an account of the 
production of neuraminidasefrom Streptomyces rig seus by induction, 
of its preparation and purification to homogeneity, of its character- 
isation as a glycoprotein of 32,000 molecular weight and of its 
structural and catalytic properties. In Chapter Three, chemical 
modification methods were employed to seek information regarding 
the nature of the amino acid residues essential in the activity of 
S. griseus, Cl. perfringens and influenza virus neuraminidases. 
In all the three enzymes the results obtained suggested that 
argin[ne, tryptophan and carboxylic groups were crucial for the 
enzyme activity. Based on these findings, a mechanism for neura- 
minidase action was proposed. 
The extensively purified neuraminidase from S. griseus was used, 
in conjunction withan isoelectric focussing technique, to investigate 
the sialylation differences in human Interferons. The results to 
these experiments, reported in Appendix I, suggest that fibroblast 
(and not leucocyte or lymphoblastoid) interferon contains neuramini- 
dase -releasable s ialic acid residues . The experiments reported in 
Appendix Il, in which rabbits were immunised with colominic acid or 
fetuin, were conducted to raise antibodies specific to sialic acid in 
an attempt todesign a radloimmunoassay for free sialic acid. 
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1. 
1. GENERAL INTRODUCTION 
1.1 Discovery of Neuraminidase 
As early as 1902 Kraus and Ludvig [1] described bacterial 
haemagglutinlns which were destroyed by heating at 580 C; the ability 
to haemagglutlnate red blood cells was later observed as a property of 
many protozoa and bacteria. Thomsen [2) and Friedenrich [31 found 
that contrary to the high specificity of native human erythrocytes in their 
reaction with iso-antibodies (isoagglutination ), the red blood cells 
exposed to different bacteria or to their culture fluids are agglutinated 
by all human sera (panagglutination). They wondered whether this 
phenomenon derived in a bacterially-caused alteration of the red cell 
membranes. 
About ten years later, Hirst [ 41 and McClelland and Hare [ 51 reported 
that chicken erythrocytes were haemagglutinated by influenza virus. Hirst 
[ 6,7] later showed thatwhen influenza viruses area Rowed to interact with 
red blood cells at temperatures near 00C. the viruses remain attached 
to the cells but are spontaneously eluted from the cells at 370 C. Hirst 
observed that the red cells from which the virus had spontaneously eluted 
would neither adsorb, nor become reagglutinated by, freshly added virus. 
The eluted virus, however, would still reagglutinate fresh cells. Something 
had changed the surface of the red cells, and Hirst proposed that an enzyme 
present on the virus particle must have been functional in destroying 
certain agglutinating receptors on the cells. 
Hirst [7] suggested the analogy of the agglutination reaction with the 
interaction of an enzyme E (on the virus particle) and its substrate S 
(receptors present at the red cell surface),, resulting in the complex ES 
equivalent to haemagglutination, viz. 
2. 
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Fig. I. I Hirst's Interpretation of the erythrocyte haemagglutin in phenomena 
Hirst's postulate contradicted a view previously held that viruses, unlike 
bacteria or higher organisms, were devoid of enzymes. However, following 
the discovery that other viruses, e. g. mumps, Newcastle disease, also had 
agglutinating activity [ 8], It was found that cells from which one strain of 
myxovirus had eluted were still agglutinable by certain other strains, 
implying that the amount or destructibility of the enzyme-susceptible 
receptors required for binding and haerrngglutination differed from strain 
to strain. 
In the course of the studies on the virus -cell interactions Burnet and his 
colleagues [ 81 furnished strong evidence in support of Hirst's view when 
they found that pretreatment of erythrocytes or host cells with a culture 
filtrate from certain bacteria, e . g. Vibrio cholerae, abolished their 
properties to agglutinate or adsorb Influenza virus. This observation was 
correlated with the earlier reports of Friedenrich [ 31 and Thomsen [ 21 
that erythrocytes became panagglutinable after treatment with culture 
filtrates of bacteria. By 1947 Burnet and his coworkers had established 
3, 
/ 
that the carbohydrate moiety of erythrocyte surfaces played a role 
in haemagglutination reactions and that this process could be inhibited 
by a number of glycoproteins [ 9,10,111. They found that the carbo- 
hydrate receptor sites on the erythrocyte surfaces and on the glyco- 
proteins which inhibited haemagglutination could be removed or 
inactivated by treatment with an enzyme present in the culture 
filtrate of Vibrio cholerae [ 12] or other bacteria [ 13], and since this 
enzyme destroyed the receptor sites for influenza viruses on the 
surface of erythrocytes it was termed 'receptor-destroying enzyme' [ 12]. 
Following the observation that influenza viral infections were 
focussed on the respiratory tract, the lining of which contains mucinous 
substances [ 14], it became necessary to conduct biochemical studies 
on the interaction between influenza viruses and mucins [ 9,15,16,17 ]. 
Thus, by associating a particular substrate with an enzymic function, 
these studies further substantiated the enzymic nature of erythrocyte 
agglutination by virus. They also showed that the phenomena observed 
on treatment of cells with either bacterial filtrates or viral particles 
were due to one and the same enzyme found in both viruses and bacteria. 
More information regarding the chemical nature of the substrate and 
the enzymic destruction of haemagglutination receptors came from 
further experiments in which (a) the product of the interaction between 
the influenza virus enzyme and ovomucin was characterised as an 
oligosaccharide containing one or more N-asyl hexosam ine residues 
[9,18], (b) the viral enzyme and the receptor destroying enzyme 
from bacteria were classified as glycosidases [ 19,24], (c) the 
product of the interaction of the receptor destroying enzyme with 
mucoproteins was isolated in crystalline form and identified as 
N-acetyl neuraminic acid, a sialic acid [20], and (d) the enzyme was 
recognised as an a-O glycosidase [ 21,23]. 
According to the nomenclature suggested by Blix et al. [24], sialic 
acid is the group name for acylated derivatives of a nine-carbon sugar, 
with an amino group in the molecule, called neuraminic acid (Fig. 1,2 ). 
4. 
Neuraminic acid never occurs in nature unsubstituted; usually it Is 
found in its N-acetylated form, or as the N-glycolyl derivative or 
as various disubstituted derivatives (ems. N, O-diacetyl). N-adetyl 
neuraminic acid and probably all other stalic acids occur in the 
pyranose formand have the 
IC 
conformation. 
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F . 1.2 Structures of some sialic acids 
S. 
Heimer and Meyer [25] suggested that the n=e'sialidase' be 
employed generally for the responsible enzyme whenever the product 
of the enzymatic action could be identified as slalic acid; since the 
destruction of receptor sites on mucolds capable of inhibiting 
influenza virus haemagglutination can be mediated by enzymes other 
than sialldase, the general term 'receptor destroying enzyme' was 
retained to describe those cases where destruction of biological 
activity alone was determined. A year later, Gottschalk [ 26 ] suggested 
the use of an alternative term 'neuraminidase' which has gained fairly 
wide acceptance. The enzyme was defined as the specific o'-glycosidase 
which catalyses the hydrolytic cleavage of the a-ketosidic linkage 
joining the potential keto group of a terminal N-acetylated neuraminic 
acid to an adjacent sugar in a disaccharide, oligosaccharide or poly- 
saccharlde [ 250 26 ]. Figurel3 shows the action of neuraminidase on 
the glycosides of N-acyl neuraminic acids. 
OH H 
HOCH 2ý 
H\ 
CH3CONH--, d 
ý`ý ý+ 
HOCH2 
DR H- 
neuramt i as 
CH3CONH 
COO 
H 
+ROH 
F iZ. 1.3 The hydrolysis of an a-ketos ide of s ialic (N-acetyl neurarr_in is ) 
acid by neuraminidase 
R= monosaccharides, oligosacchar ides, glycoproteins, glycolipids, 
aliphatic or aromatic alcohols. 
Today the enzyme is listed by the International Union of Biochemistry 
under the systematic name 'Mucopolysaccharicje (or glycoprotein ) 
N-acetyl neu raminylhydrolase EC 3.2.1.18'according to Enzyme 
Nomenclature, 1965, [281, while retaining 'neuraminidase' as the 
recommended trivial name. The name 'sialidase' as originally proposed 
G. 
by Helmer and Meyer [ 251 is preferred by many investigators who 
feel that this name is in better agreement with the presently proposed 
nomenclature of slalic acids [24] and that 'sialidase' is the more 
correct term because neuraminic acid (implied In the alternative term 
'neuraminidase') is neither the product of the enzymatic action nor 
the 
stable enough to exist per se in nature. Nevertheless/term'neuraminidase' 
appears to have a more universal use as is clearly attested by the titles 
and texts of many papers and reports (including this thesis ). 
1.2 Occurrence and Distribution of Neuraminidases 
Neuraminidases comprise a group of rather diverse origin. They 
have been found in viruses, bacteria, protozoa and vertebrates. 
Neither neuraminidase nor sialic acid has so far been detected in 
plants. 
1.2.1 Neuraminidase in viruses 
As mentioned above, neuraminidase was the first enzyme to be found 
in a virus [6] and indeed was for a long time , after 
its discovery the 
only virus specific enzyme known to be an integral part of myxoviruses ; 
it is only In the last few years that other enzymes, e. g. RNA- and DNA- 
polymerases, endo- and exo-nucleases and phosphohydrolases have 
also been associated with the virus particle. 
Occurrence of tieuraminidase in viruses is restricted to the ortho- 
myxovirus and paramyxovirus groups and not in other classes of virus. 
Indeed, myxoviruses were originally defined as those viruses 'having 
special affinity for mucins' [29], reflecting the presence of neuraminidase 
on their surfaces. From electron microscopic examinations, it has been 
suggested that viral neuraminidases are located on the surface of the virus 
where they form a significant feature of the surface morphology of the 
virus [30]. For parainfluenza viruses , the 
haemagglutinin and neura- 
minidase activities appear to reside on a single glycoprotein, although in 
the case of the Influenza viruses the activities reside in different glyco- 
prote ins [ 31 ] (see F ig. 1.4). 
7. 
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Since the synthesis of this enzyme is directed by the viral genome, 
neuraminidase from different viral strains have different antigenic, 
kinetic and physicochemical properties; also there is a several-fold 
difference in the amount of neuraminidase incorporated into a virus 
[321. Depending on the virus strain and conditions of detection and 
isolation of the enzyme, neuraminidase generally represents 5 to 10% 
of the total viral proteins [ 30 ). 
Table 1 summarises the occurrence of neuraminidases in myxo- 
viruses, essentially as listed in recent reviews on neuraminidases 
[330 34] except that influenza C has been omitted. 
Hydrophobic surface 
S. 
Table 1. i Occurrence of neuraminidase in viruses 
Group Type of virus 
Human influenza, type A 
Orthomyxovtruses Avian, porcine, equine influenza 
Human influenza, type B 
Newcastle disease 
Paramyxov[ruses Mumps 
Parainfluenza, types 1,2 and 3 
An earlier report that Influenza C virus contains neuraminidase 
[35] has been revised, and it is now thought that influenza C has a 
receptor destroying enzyme which does not possess the enzymatic 
properties of neuraminidase but has an analogous effect on Its own 
receptor, enzyme and haemagglutlnating activity [ 36 ]. Also measles, 
distemper and rinderpest viruses classified as paramyxoviruses have 
been found to Contain no neuraminidase. There has been no report in 
the literature that neuraminidase occurs in parainfluenza type 4 virus. 
It is interesting that viruses such as Influenza which contain neura- 
minidase lack siallc acid In their surfaceglycoproteins, presumably 
as a result of the viral neuraminidase activity ( 371 while viruses such 
as Sindbis or rabies in which no neuraminidase has been detected contain 
stalic acid residues at their surfaces. 
1.2.2 Neuraminidase in protozoa and bacteria 
The history of bacterial neuraminidases dates from the time of Burnet's 
concept of the existence of a receptor destroying enzyme [8,12] which was 
first detected in Clostridium perfringens [ 13 ] and later in Vibrio 
cholerae [ 12]. The discovery of neuraminidases in bacteria and protozoa 
then entered a logarithmic phase and today more than 60 neuraminidases 
from different bacteria and protozoa have been described. Müller [39] 
has reviewed the occurrence of neuraminidases as reported in bacteria 
and protozoa in theperiod 1947-1974. 
9. 
Bacterial neuraminidases are either cell-bound or are excreted into 
culture filtrates. For most bacteria the production of neuraminidase can be 
greatly enhanced by induction witn free or bound s is lic acid. [ 38,40] . 
Recently 
one thousand microorganisms were screened for the production of neura- 
minidase s colmminic acid as. the sole our of carbon in the culture 
media[ 01. at genic microorganisms -ucn as 
Lorynebacteria, 
Bacteriodaceae, Clostridia, Vibrios, Streptococci, Pasteurellae, 
Kiebsiella aerogeaes, Erysipelothrix insidiosa, Mycoplasma 
gallisepticum and the protozoa Trichomonas foetus tend to produce more 
neuraminidase than non-pathogens. Indeed, some authors have 
correlated the pathogenicity of these microorganisms with neuraminidase 
activity [39]. A few non -pathogenic bacteria, e. g. Lactobacillus 
bifidus [421 and Streptomyces griseus [431 have been found to produce 
neuraminidase. Microorganisms which possess sialic acid have weak 
or no neuraminidaseand acylneuraminate-pyruvate lyase (NANA lyase, 
NANA aldolase EC. 4.1.33 ) activities. Bacteria which are well 
established neuraminidase producers also possess NANA-lyase but 
their cells do not contain sialic acid. It is possible that strong 
neuraminidase-producers have evolved their ability to produce the 
enzyme as Ceir adaptation to the inhabitation of sialic acid-containing 
substances , e. g. the respiratory and intestinal tracts 
[ 44 ]. 
1.2.3 Distribution of neuraminidases in vertebrates 
Neuram Inidase activity has been detected in different organs of 
birds and mammals [ 33,34,45 ]. The enzyme activity is high in those 
organs, ems. . liver, brain, kidney and mammary glands which are 
associated with a high metabolism of sialic acid and its derivatives 
[461. Whereas vertebrate species all contain substrates for neura - 
minidase, viral and bacterial species which produce neuraminidase 
appear to contain no substrates for it. Most of the neuraminidase 
activity within calf brain has been found in grey matter where it is 
mainly associated with the synaptosome membrane [47]. In animal 
cells neuraminidase is bound to lysosomes, but has also been found 
associated with other organelleseg. microsomes and mitochondria (48'j. 
In a number of tissues neuraminida eactivity has been shown to vary 
with the age, physiological function and condition of the tissues 
concerned. 
10. 
1.3 Importance of Neuram in idases 
Sialic acids occur widely if not universally as terminal carbo- 
hydrate residues in glycoproteins, glycolipids and polysaccharides 
and also form a quantitatively important structural part of the cell 
surface. The participation of sialic acids in the functions of these 
substances has achieved widespread recognition through extensive 
studies in which the selective removal of sialic acid residues with 
neuraminidase has been associated with altered properties of the 
normal sialylated structures. The biological functions in which 
the Involvement of sialic acid has been suggested include: cell-cell 
interactions, cellular transformations, blood clot formation, 
alteration of the half-life of circulating sialocompounds, neuro- 
transmission, transport, Interaction of hormones with their target cells, 
immunological properties and reproduction. In addition to the metabolic 
significance ofneuraminidase in these physiological phenomena, 
neuraminidase function has been implicated in pathogenesis and its 
therapeutic efficacy has been assessed. It has also been employed as 
a tool in various structural Investigations. 
1.3.1 Some effects of neuraminidase on cell surface properties 
Sialic acids may have direct or indirect biological roles as has 
recently been emphasised in a number of reviews on the chem Istry 
and biology of cell surfaces [ 49,50,51,52,53 ]. The indirect roles of 
sialic acid attributed to the masking of cell surface antigens and other 
receptors can be ascertained by the enhanced antigenicity or other 
interattianmcreated bythe removal of sialic acid residues from the cell 
surface [54,55]. 
The direct roles of sialic acid result either from the chemical 
properties of the carboxylic group or from the rigidity of the membrane 
due to the chemical properties imparted by the charged groups. In 
these respects stalic acid may be involved; 
(a) in nonspecific repulsion of cells or macromolecules by virtue of Its 
strong negativip charge [ 56,57 J, 
11. 
(b) as a receptor for: 
(i) various lectins [58,59] 
(ii) virus particles[ 60,61,621 
(iii) mycoplasmas [631 
(iv) antibodies to cell surface antigens [ 64,651 
(v) hormones [66,67] 
(vi) circulating glycoproteins (except transferrin) [68] 
(vii) tetanus toxin [69], 
(c) In cell-cell interactions; 
(I) attachment of cells to Inactive supports (adhes ion) [ 701 
(ii) attachment of cells to each other (aggregation) [ 71,72,73 ] 
(iii) attachment of cells to antibodies, other proteins, charged 
polymers or blood components [ 74,75 ], 
(d) In maintaining cell surface rigidity [ 56,76 
(e) In physiological events: 
(i) stimulation of phagocytos is [57,771 
(it) transport of Ions, amino acids, proteins [ 78,79,80] 
(tit) synaptic transmission and brain excitability [ 81,82] 
(iv) life -time of cells and s talo compounds [83,841 
(v) reproduction [ 85,86,871 
(f) In normal and malignant or transformed cells [ 88,89,90] 
Although the exact role of cell surface sialic acid is not yet clear in 
the cellular functions mentioned above, it is interesting to note that its 
removal from the cell surface with neuraminidase is associated with a 
variety of altered properties of these cells(Table 2). 
It is also interesting that the total cell surface sialic acid changes 
throughout the cell cycle : sialic acid increases before cell division and 
decreases after the onset of mitosis [>9,100,1011. Further, old 
erythrocytes have less surface sialic acid than young cells and it is now 
established that sialic acid-deficient cells are recognised and removed 
from circulation. 
The possibility that cellular neuraminidase activity is involved in 
these events, perhaps as a controlling mechanism for growth and 
metabolism, is being explored in many laboratories. 
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Table 2 Some effects of neuram inidase on cell surface properties 
1. Reduces electrophoretic mobility (and negative charge) of a variety 
of cells [ 49,52,531. 
2. Changes homing properties of lymphocytes [ 91) . 
3. Increases deformability of cultured cells [ 561 . 
4. Increases rosette -form Ing ability [ 92 ]. 
5. Decreases pinocytic behaviour of the cell surface [ 52,53]. 
6. Increases susceptibility to phagocytosis of cells [57]. 
7. Alters transport of K+ ions across cell membrane [78]. 
8. Decreases accumulation of n' -aminoisobutyric acid in cells [79]. 
9. Alters viral-induced hameagglutination [52]. 
10. Reduces adrenal respon se to ACTA [ 66 , 
67 ]. 
If. Increases adrenal response to cholera enterotoxin [92]. 
12. Shortens erythrocyte lifetime [ 83,84 ]. 
13. Reduces penetration of ova by sperms [ 93 ]. 
14. Suppresses pregnancy [94]. 
15. Increases Immunogenicity of various cells [52,53,95]. 
16. Increases cytolysis of cells by the immune components [96]. 
17. Increases platelet aggregation [ 75 1. 
18. Detaches cells from glass substrate [ 70 ]. 
19. Delays mouse skin graft rejection and skin hypersensitivity [97]. 
20. Regresses mammary carcinoma [52,531. 
21. Inhibits release of proteins [ 80 ]. 
22. Abolishes synaptic transmission in synaptic structure [ 81 ]. 
23. Generates cell-mediated cytotoxicity [52,53]. 
24. Reduces response of smooth muscle tissue to serotonin [52,531. 
25. Destroys virus receptors [71. 
26. Stimulates celldivision in cells at confluence [98]. 
27. Reduces precipitation of cells with protamine sulphate or 
hexadimethr ine bromide [74]. 
ACTH - Adrenocorticotropic hormone 
13. 
1.3.2 Some effects of neuraminidase on glycoproteins 
Treatment of various glycoproteins and other sialic acid-containing 
substances with neuraminidasehas been shown to destroy or modify 
their biological activities and change such physicochemical properties 
as electrophoretic mobility, heat- and pH-stability, solubility, and 
microheterogeneity. 
1.3.2.1 Biological activity of glycoproteins 
The effects of experimental removal of sialic acid from biologically 
important sialic acid-containing substances with microbial neuramini- 
dases have been reviewed in detail by several authors [ 49,521.102,103, 
104]. 
1.3.2.2 Stability and kinetic properties of glycoproteins 
Results from several investigations have led to the thought that sialic 
acid may influence the stability and kinetic properties of glycoproteins. 
with neuraminidase 
Treatment of human Tamm and Horsfall urinary glycoprotein / resulted 
in an increase In the number of low pK tyrosine groups and in an increase 
in the number of titratable arginine groups [ 105 ], possibly suggesting 
that the carboxyl groups of sia lic acid and the hydroxyl groups of 
tyrosine or arginine are directly hydrogen -bonded together. Some 
glycoproteins show considerable resistance to enzymatic proteolysis 
unless their slalic acid is first removed, e. g. with neuraminidase 
[ 106,107] and, as mentioned earlier, such removal of terminal sialic 
acid has been 'shown to result in rapid elimination of the glycoprotein 
from plasma and uptake by the liver cells [ 84]. 
The stability of y-glutamyltranspeptidase in acid was increased by 
neuraminidase treatment [ 1081 and treatment of acid phosphatase with 
neuraminidase increased its optimum pH, substrate affinity and 
sensitivity to inhibition [ 109]. Enzymatic removal of sialic acid from 
choline esterase gives rise to a mixture of kinetically distinguishable 
forms of enzymes, one of which was specific for acetylcholine only 
[ 110]. Sialic acid has also been suggested as the component 
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responsible for the low isoelectric point, high electrophoretic 
mobility and chromatographic, electrophoretic and immunologic 
heterogeneity. Often the enzymatic removal of s ialic acid will 
reduce or remove the heterogeneity, and in the case of isoenzymes 
the presence of subunits can be distinghuished from the occurrence 
of different charges in different forms of the enzyme [ 111 ]. 
1.3.3 Neuraminldase in metabolism and physiology 
The important roles of sialic acid, most of which have been 
suggested above, must inevitably apply to neuraminidase as well. 
In this section, therefore, the significance of neuraminidase upon the 
chemical and physiological state of its endogenous substrates and upon 
the functional aspects of other biological activities , ems, cell-cell 
Interactions, growth and evelopment of malignancy, reproduction, 
hormonal, enzymatic and Immunological activity, and neurotrans - 
mission will be discussed only briefly. The turnover of glycoproteins 
and their physiological functions have been discussed[ 112,113]. The 
In vivo functions of neuraminidase as well as the effects of activators 
and inhibitors on Its activity must assume a central role in the 
metabolism of these substances. 
Various effects of neuraminidase upon different hormones have been 
described; for instance Lt'inhibits' insulin secretion [ 114] has Insulin- 
like stimulating action [ 115] and inactivates some of the hormones 
involved in reproduction of chorionic gonadotropin (HCG) and follicle- 
stimulating hormone (FSH) [ 1161. Removalof sialic acid groups from 
cell surfaces by neuraminidase suppresses collagen synthesis [ 1171, 
inhibits the release of proteins from cells and alters the K+ and Na+ 
flux [ 1181. It Is Interesting that the (K+' Na+)-activated adenosine 
triphosphatase in plasma membranes contains sialic acid [ 1191. 
Evidence has accumulated favouring the role of neuram inidase in 
regulating the catabolism of a wide rangeof sialic acid-containing 
substances, In cells, glycoproteins and polysaccharides. Exposure of 
terminal non-reducing galactosyl residues by removal of sialic acid 
provides a means by which the liver recognises and removes the defective 
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molecule from circulation [ 84]. This may be their normal catabolic 
pathway. It is Interesting that substances such as lysozyme and 
albumin which are not normally cleared from circulation by rat liver 
are cleared if covalently linked to desialysed fetuin [ 1201. 
Neuraminidase may be involved in the control of Immune processes, 
acting to unmask antigenic determinants on cells or other substances 
by removing stalic acid residues and increasing immunogenicity [95]. 
Neuraminidasehas also been shown to Increase the non-specific 
fixation of immunoglobulins to erytLrocytes [ 1211 and, together with its 
enhancement of cytolysis of treated cells by the immune components [961, 
this may be another mechanism for the destruction of defective 
molecules. As well as influencing the immunological apparatus, the 
principle of masking bysialic acid may well be at work in cell-cell 
and cell-glycoprotein interactions, in which events neuraminidase may 
be Instrumental in their regulation. 
Essentially all lysosomal hydrolytic enzymes of rat liver and 
kidney are glycoproteins and some contain sialic acid which is 
responsible for their solubility, acidity and high electronegative charge ; 
the acidic, more soluble forms of these enzymes can be converted to 
the basic forms by treatment with neuraminiJase [ 1221, but the 
biological significance of such enzyme multiple forms is still unclear. 
However, since these forms differ in solubility, pH stability, pH optimum 
and charge, they would be expected to possess different hydrolytic 
activities under physiological conditions. The inhibition of alkaline 
phosphatase [ 123] by sialic acid is perhaps another point of metabolic 
regulation effected by neuraminidase. The induction of vertebrate 
cellular neuraminidase by its substrates is not documented, but it is 
well known in bacterial neuraminidases [41,42]. However, when 
investigating the appearance of neuraminidase activity in the course 
of vertebrate development, Carubelli [ 1241 obtained results indicating 
that vertebrate neuraminidase, in analogy to bacterial neuraminidases 
might also be adaptive enzymes. Carubelli andGriffin [125, later 
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observed elevated neurarinidase activity in HeLa cells grown in the presence 
of hydrocortisone. Although this rise in activity is obviously not due to 
specific enzyme induction by substrates or related substances, the finding 
indicated that neuraminidase production in vertebrate tissues, like that in 
bacterial systems may be under regulatory control. 
Several investigators have reported that neuraminidase content in brain 
tissues is often related to the amount of its endogenous substrates [ 126] and 
that Its activity on'brain gangliosides may be influenced by ionic strength 
[ 127]. It has also been observed that Intoxication in rats leads to high levels 
of lysosomal neuraminidase and decreased Golgi neuraminidase [ 128], while 
hypercapnia and the associated respiratory acidosis is believed to be 
responsible for the activation of brain glycosidases Including neuraminidases 
[ 129]. The metabolic diseases discussed below also implicate neuraminidase 
in metabolic functions. 
1.3.4 Neuraminidase and disease 
1.3.4.1 Metabolic diseases 
In a few cases the activity or lack of activity of neuramin idase has been 
thought to directly or indirectly Influence the establishment of disease 
conditions in which the amounts of neuraminidase susceptible substrates are 
accumulated or are deficient in abnormal proportions. In other instances, 
however, the abnormal levels of the enzyme or its substrates have not been 
shown to be parallel. 
Deficiency of various lysosomal hydrolases, including neuraminidase, have 
been associated with mucolipidoses, congenital disorders deriving in abnormal 
storage of glycoproteins and/or glycolipids [ 129]. Recently another form of 
mucolipidosis in fibroblasts was shown to be associated with increased sialic 
acid and deficiencyof neuraminidase, but no other lysosomal hydrolase [ 130 ]. 
Reviewing the various forms of sphingolipidoses caused by the lack of specific 
hydrolytic enzymes, Brady [98] has suggested that in Tay-Sachs disease and 
in generalised gangliosidosis, neuraminidase may be present only in low 
amounts or may be absent. However, the more recent finding of similar levels 
of neuraminidase in brain tissues from normals and cases of Tay-Sachs disease 
[ 160] is not in keeping with such a view. 
A lowcontent of platelet sialic acid was observed in two cases of 
congenital thrombocytopenia with giant platelets [ 1311, and can be 
correlated with the marked thrombocytopenia observed after injection of 
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neuramin idase into mice, rabbits and rats [ 132 1. Further, persistent 
polyagglutinatibility involving all the blood cells of one patient has been 
shown to be related to apartial deficiency of sialic acid residues at the 
surface of the erythrocytes [ 133]. In these studies, however, the low 
levels of sialic acid were not correlded with the neuraminidase content 
nor were the high levels of sialic acid content of blood from patients 
with coxarthrosis [ 134]; It is possible that the altered levels of siallc 
acid result from changes In the activity of the enzymes, including 
neuraminidase, which regulate its metabolism. 
Excretion of sialic acid In urine was found to be predominantly in 
the bound form in kwashiokor while normal children excreted this 
compound largely in the free form [ 1351. The abnormally viscous 
secretions In pancreas, lungs and Intestinal tract of patients with 
cystic fibrosis are thought to arise from faulty glycoprotein metabolism. 
The salivary mucins of patients with this disease were found to be more 
resistant toexoglycosidases e. g. neuraminidase, of bacterial and 
glandular origin. A raised level of uromucoid (a substance related to 
the Taman and Horsfall glycoprotein in urine) was reported in patients 
with calculous disease [ 1361 but neither has the relationship between 
uromucoid and the process of calcification nor the correlation between 
neuraminidase activity and the high levels of this glycoprotein been 
reported. However, by virtue of their sialic acid content, glycoproteins 
are capable of binding calcium [ 1371 and per"haps i-iitiate the 
formulation of a calculus. 
1.3.4.2 The role of neuraininidase in pathogenic microorganisms 
All living organisms need to adapt themselves in the most 
advantageous fashion on their environment, and this is apparent in the 
successful adjustment of pathogenic viruses, protozoa and bacteria to 
their selected hosts. The ability to induce enzymes which enhance their 
adaptation potential contributes to this success. Neuraminidase is still 
probably the best example of such enzymes. Correlation between neura- 
minidase elaborated by pathogenic organisms and their life styles is 
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diff icult, but it is of interest to note that neuram in idases from pathogens 
show higher affinity for their substrates and are produced in higher 
amounts than neuraminidases from non-pathogens [ 138]. 
The substrates of neuram inidase are widely distributed in animal 
tissues, secretions and excretions. Invading pathogens will encounter 
in their new environment in the host adequate numbers of inducers and 
substrates; the glycoproteins and cell membrane glycoconjugates, the 
protective mucus liniref respiratory systems, oral cavities, gasto- 
intestinal tracts, urinary genital, lachrymal and nervous systems = all 
will possess chemicalgroupings which will Induce the synthesis of 
neuraminidase whose effect and that of other enzymes present is to 
remove stalic acid and subsequently other sugars which can serve as 
a ready source of energy for the parasites. Neuram Inidase serves to 
modify the physicochemical characteristics of the protective mucus 
meant to hinder close approach of other cells. and by Its adhesiveness to 
entrap invading microorganisms. Gottschalk [ 1391 described the patho- 
mechanism of influenza in the respiratory tract which, in molecular 
terms proceeds by decreasing the viscosity of mucin. Neuraminidase 
may thus be a powerful weapon of these parasitic organisms to be used 
when they are threatened with solitary confinement in a coating of 
adhesive and protective host mucin. This way the host is exposed to more 
infection. Further, the mechanism of the host immune response Is made 
less effective because: 
(i) Ig A, which is the major antibody response , occurs only after the 
early highly virulentphase of the disease, and is itself an inducer and 
substrate of neuraminidase. Although the desialytion of IgA by neura- 
minidase affects neither the affinity nor the antibody specificity [ 140 
Its efficiency as a defence mechanism will depend upon the relative 
rates of proliferation of the pathogen. 
(ii) The other defence mechanism is perhaps the cell-mediated immune 
response involving the B and T type lymphocytes , 
both of which possess 
terminal sialic acids. When these sialic acid residues are removed by 
the neuraminidase of the pathogen, the lymphocyte's response to 
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mitogenic stimuli is enhanced and the presence of the pathogens will 
activate macrophages, leading to the release of hydrolytic lysosomal 
enzymes, of which lysozyme will damage lysozyme-sensitive micro- 
organisms and neuraminidase will destory the host's protective mucus 
lining and cell membranes, thus contributing to an inflammatory 
response [ 142 ]. 
In some cases a direct link has been established between the ability 
of these organisms to synthesise aeuraminidase and their pathogenicity. 
The pathology of microbial neuraminidases has been reviewed; 
numerous sources of the enzyme were considered and diseases 
associated with neuraminidases were tabulated [39.1431. However, 
some authors have not favoured such direct role for neuraminidase 
activity in pathogenic microorganisms. Thus White and Mellanby [ 144] 
were able to separate neuraminidase activity from the oedema- 
producing, haemorrhage-producing and lecithinase activities, and 
other workers [ 145] found no correlation between animal virulence 
of D. pneumoniae and its ability to produce neuraminidase. It Is 
Interesting, however, that Fedoseeva et al. [ 1461 observed a direct 
relationship between the elevated levels of free sialic acid and the 
bronchopulmonary process in children with chronic pneumonia and 
asthma. Burton [ 147] reported that the neuraminidase of Clostridium 
perfringens was not toxic to mice whereas, in other reports, neuramini- 
dase was thought to be the causative agent in the toxicity of the 
component produced by Clostridium perfringens in food poisoning [ 148]. 
Also the factor in the culture filtrates of Vibrio cholerae which 
Inhibited the sodium pump of frog skin was shown to be different from 
the Vibrio cholerae neuraminidase [ 1491. 
1.3.4.3 The role of neuraminidase in viral infections 
to the case of viral infections there have been a number of 
conflicting lines of evidence in support of different roles of viral 
neuraminidase in the replication of viruses. The original suggestion 
of Hirst [7] that neuraminidase assists in the penetration of the virus 
into the host cell by cleaving sialic acid residues from cell surfaces 
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has been doubted following observations that heat-inactivation [ 1501 
or proteolytic removal [ 1511 or inhibition [ 1521 of viral neuramini- 
dase does not affect the infectivity of the virus, suggesting that 
neuraminidase is not essential in the early stages of influenza 
virus replication. In other reports, however, the inhibition of 
viral neuramiaidase with 2-deoxy-2,3-dehydro-N-acetylneuraminic 
acid [ 153] or with 2-deoxy-2,3-dehydro-N-trifluoro-acetyl neura- 
minic acid (FIg . 
1.5) [ 154] inhibited the replication of influenza 
viruses. It is possible that the attempts to exclude neuraminidase 
activity from the virus particle may not have been completely 
effective so that some residual neuraminidase activity remained 
functional. Other neuraminidase inhibitors such as phenylglyoxal or 
phenylglyoxamlc acid have not been shown to inhibit viral replication. 
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The role of viral neuraminidase in binding myxoviruses to host 
surfaces was suggested in severa 1 reports, e. g. [ 155,156 ] 
following experiments in which the removal of sialic acids from 
cell surfaces giminished or completely prevented the attachment 
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of viruses to cells. Later the function of sialic acid in such 
attachment was further confirmed using artificial lipoprotein 
membranes which bound myxoviruses but not rhinoviruses or 
herpes viruses [ 157]. Other observations, however, did not 
favour the idea that an enzyme-substrate interaction was responsible 
for the bindingof virusesto cells. For instance, it had been noted 
earlier that aeuraminidase-specific antibodies neither affected the 
agglutination of red cells by myxoviruses [ 158] nor the binding of 
myxoviruses to erythrocytes [ 159] ; moreover, the neuraminidase 
liberated and purified from the virus failed to adsorb to red cells 
[1591. However, these studies are not necessarily conclusive, 
especially in view of the existence of variations in both the 
specificity and viral content of neuraminidases in even antigenically 
identical virus recombinants [ 321. 
The role of neuraminidase in the release of progeny virus from 
the cell surface has also been suggested [ 1611 mainly from 
observations on the effects of antibodies to viral neuramin idase on 
viral replication; but Kendal and Madeley [ 1621 and Becht et al. [ 1631 
have concluded that the observed effects of antibodies to neuramini- 
dase were not due to their Interference with neuraminidase enzymic 
activity but rather arose from binding virlons to each other and 
to infected cells. The viralenzyme is therefore not responsible for 
the release of myxoviruses from the cell surface. In addition, the 
time of maximal neuraminiclase production in an infected cell is 
long before the release of the virus [ 1641. 
Nevertheless, there is mounting evidence suggesting correlation 
between immunity to viral infection and the presence of antineuram in i- 
dase activity, Antibodies against purified viral neuraminidase have 
protected mice [ 165], cattle [ 166] and man [ 167] against influenza. 
Also the inhation of neuramin idase to destroy the receptors for the 
virus protected mice from influenza [ 168], and in similar experiments 
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Cairns [ 169 ] obtained a moderate degree of protection against 
intracerebral infection of a neurotrop ic variant of i of l uenzasý 
ra 
i nssg/ 
f 
innoculation of large amounts of neuram in idase. Interferon, a 
cellular antiviral substance, was shown to suppress the production 
of neuraminidase in thegrowth of influenza virus in chick embryo 
cell cultures [ 170 ]. 
One so far unquestioned role of neuraminidase in the replication 
of viruses is the part it plays in viral assembly by preventing 
aggregation. It is known that viruses which contain neuraminidase 
possess no sialic acid residues, presumably due to the function of 
viral neuraminidase [371. If sialic acid residues were incorporated 
in virions contalningneuraminidase, theywould serve as receptors 
for the viral haemagglutinin and result in aggregation and consequent 
low yield of infectious virus. Thus neuraminidase protects the virus 
from its own agglutin in. 
1.3.5 Direct applications of neuraminidases 
Since theirdiscovery, neuraminidases have been used a great deal 
in research to study their effects on the removal of sialic acid 
residues from cell surfaces and various other biologically important 
slalic acid-containing compounds, e. g. enzymes, hormones, glyco- 
lipids, etc., many of which were discussed above. Most of these 
studies have been conducted with microbial neuraminidases since the 
viral enzyme is often unavailable in sufficient amounts. The 
alternative chemical methods of removing sialic acid from its natural 
partners, e. g. acid hydrolysis, methanolysis, often are not specific 
and can be incompatible with most properties of the substances under 
study. 
In addition to their value in assessing the content . the 
biological 
function and the nature of the linkage of sialic acid in glycoproteins 
etc., neuram in idases have been used to remove s is lic acids from 
glycoproteins and thus correct for the amide nitrogen arising out 
of sialic acids during acid hydrolysis of glycoproteins [ 171 ]. 
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The differences In the properties of neuraminidases from 
different sources have been proposed as a basis for the 
classification of viruses [ 172] and vibrios [ 138. 
Some viruses have been purified by virtue of their neuramini- 
dase content. Thus influenza viruses can be concentrated and 
purified by adsorbing on to red blood cells at 
4 C, raising the 
temperature to 370 C after the cells have been washed free of 
impurities, and recovering the purified virus by centrifugation [173]. 
Similarly theneuraminidase inhibitor, 2-nitrophenyloxamic acid, 
was used to purify neuraminidase-containing viruses [ 1741 and 
recently immobilised neuraminidase was used to purify 
Interferon [ 1751. Neuraminidase has also been used as a means 
of assaying the biological activity of interferon [ 1761. 
The potential of neuraminidase in the therapy of viral infections 
has been assessed by a number of Investigators. Protection 
against viral Infections by antibodies to neuraminidase [ 165-1671 
or by treatment with neuraminidase Itself [ 168,169] was mentioned 
above, and although these methods of Inhibiting viral replication 
have not so far gained clinical use, further studies may make It 
possible. Treatment ofnormal or malignant cells with neuraminidase 
Increases their immunogen icity and imparts an increased antitumour 
activity [ 52,53,95,177]. The Induction of an immune response 
towards tumour-specific antigens during natural antibody -initiated 
clearance of neuraminidase-treated cells is thought to be the 
mechanism underlying the therapeutic effect observed following 
innoculationof tumour-bearing rodents with neu ram in ida se -treated 
cells [ 177], but whether this method of immunotherapy can be 
applied to the clinical management of human cancer is yet to be 
established. 
1.3.6 Interpretations of the experimental use of neuraminidases 
There have been many conflicting reports relating to the 
interpretation of the results obtained, especially following the 
removal of stalic acid residues from whole cells. Treatment of 
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cells with neuraminidase is not considered to be too harmful since, 
in the case of red cells, the properties of osmotic fragidity 
autohaemolysis at 370 C, K+ retention and pyruvate kinase 
activity of untreated cells are maintained [ 521. However, it has 
been shown that neuraminidase can enter [ 178] or bind to [ 1791 
cells, both of which phenomena could lead to various effects, (e. g. 
masking of adjacent functional groups, breakdown of metabolites, 
etc. ), and thus cause aberrant behaviour not related to the specific 
group or function under study. Recently Parker et al. have described 
the use of immobilised neuraminidase which promises to alleviate 
such technical problems [ 1881. The interpretation of the effects of 
neuraminidase on cells etc. and their function is further 
complicated by the considerations that different cells contain 
different types of glycosidic linkages in various proportions which 
are cleaved to different extents by neuraminidases from different 
sources [ 33,340 53 ]. This will be discussed in the next chapter. 
Although the particular biological function may be related to a 
specific glycol idic linkage, the removal of s is lic acid may be 
non -specific and some of the sialic acid residues may be resistant 
or poorly hydrolysed either by virtue of the a -ketosidic linkage or 
because of steric hindrance. Often the substances on which the effect 
of neuraminidase is studied may have been originally obtained from 
tissues also known to contain neuraminidases, and the cases in which 
experimental addition of neuraminidase were seen to have no effect 
may well be due to the previous function of tissue neuramin idase 
in vivo, after death or during the preparation of the substance under 
investigation. 
Lastly, the definitive information obtained by using neuraminidase 
to modify cell membranes, glycoproteins, etc. must depend on having 
a rigorously purified enzyme or otherwise establishing that the effect 
is due to the enzyme under investigation. Observations by Kraemer 
[ 180] that commercial neuraminidase contained cytotoxic, haemolytic 
and phospholipase activities demonstrated the necessity to further 
purify the enzyme before its use in establishing the biological roles of 
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sialic acid. Another serious contaminant of the commercial enzyme 
is proteolytic activity [ 1811. Considering that most of the neura- 
minidase preparations employed in these studies were never 
evaluated for contaminants and were used without purification 
beyond commercial quality, the results obtained are necessarily 
difficult to interpret. For instance, loss of homing properties 
similar to that observed on treatment of lymphocytes with neura- 
minidase has been observed after treating the cells with trypsin 
[182], and cell surface trypsin -mediated proteolysis has been shown 
to modify cell growth [ 183], experimental pulmonary metastasis 
[ 184 ], cell agglutinability [ 1851 and aggregation /adhesion [ 4,86 ]. 
1.4 Aim of the Project 
Clarification of these conflicting results and the definition of the 
exact role of neuraminidase will inevitably follow the complete 
characterisation of the enzyme. 
Neuraminidase has for the most part, since its discovery, been 
studied by virologists interested in the virus or by cell-biologists 
Interested In assessing the function of sialic acids through their 
removal from cell surfaces or other sialic acid-containing cellular 
metabolites, and by chemists interested In it as a tool In structural 
Investigations. Bacterial neuraminidases have been, and are 
presently, regarded by some as model substance of the viral 
enzymes studied mainly because of lack of sufficient viral material. 
Soy although it is over thirty years since the first neuraminidase was 
studied as an enzymic entity [ 12], the detailed chemistry of the 
structure and function of these enzymes is still obscure. However, 
a great deal of work has been done on the enzymic action of neuramini- 
dase on differerLt natural and synthetic substrates as well as its 
Inhibition by various chemically defined inhibitors. The kinetic and 
physical properties described for neuraminidases from different 
sources have revealed certain important features of these enzymes. 
26. 
Having introduced the biological importance of neuraminidase 
(although for the most part yet uncertain) , 
it is difficult to 
exaggerate the necessity for accumulation of enough knowledge 
about the enzyme's chemical properties in attempts to define 
more exactly its function In molecular terms. The greatest 
emphasis in tt'e studies described below will therefore be on 
chemical properties of different neuraminidases with a view to 
understanding the way in which their functional properties are 
the phenomena that their structure must explain. 
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CHAPTER TWO 
PROPERTIES OF NEURAMINIDASES 
2.1 Introduction 
The properties and differences of neuraminidase from different 
sources have been described in recent reviews [33,34,45,102,187]. 
Generally bacterial and vertebrate neuraminidases occur as single 
polypeptides with molecular weights in the range 50,000-100,000, 
although some bacterial neuraminidases with molecular weights below 
and above this range have been reported [ 43,187,189 ]. Viral 
neuraminidases possess multiple polypeptide chains , 
have molecular 
weights in the neighbourhood of 200,000and their pH optima are 
closer to neutrality than the rather acidic pH optima generally found 
for bacterial and vertebrate neuraminidases. The occurrence of 
multiple forms of neuraminidase has been observed mainly from 
chromatographic indications of more than one peak of neuraminidase 
activity during purification of this enzyme from a number of bacteria 
[ 190,191 ]. Whether this microheterogeneity of neuraminidase 
preparations was due to genuine genetically determined isoenzymes or 
to the aggregation and disaggregation of molecules, or to differences in 
conformational states, or to differences In subunit dissociation and 
recombination or to heterogeneity in ligand binding,, or to the effects of 
contaminating proteases or simply to the formation of artefacts has not 
been established. The data presented by Tanenbaum and Sun [192] 
restricts tie choice of hypotheses for the manifestation of isoneuramini- 
dases [ 190 ] to those involving charge differences and indicate a lack 
of subunit structure for such multiple forms. In the cases in which the 
multiple forms of neuraminidase were reported, no affinity chromato- 
graphic separation step was involved; further, the specificities of the 
different forms of neuraminidase towards different sialic acid substrates 
were not investigated. The substrate specificity, kinetics, metal ion 
requirement or inhibition bydifferent agents varies with the source of 
the enzyme and with the substrate used. 
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In natural substrates of neuraminidase (Figure 2.1), carbon 2 of 
sialic acid is either linked to carbon atom 3.4 or 6 of galactose, 
carbon atom 6 of N-acetylgalactosamine or N-acetyl-D-glucosamine or 
to carbon atom 8 of a second sialic acid molecule [ 193]. 
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Figure 2.1 (arrow). Action of neuraminidase on the possible 
glycosdic linkages between sialic acid and the 
penultimate sugar in a neuraminidase substrate. 
With few exceptions [33,34,45,102,187] bacterial and vertebrate 
neuraminidases cleave most a-ketosidic linkages (a-2 -y 3, a-2 -» 4, 
r-2-º 6 and o-2-" 8), although with differing ease, depending on the type 
of substrate enzyme source and analytical conditions. In contrast, 
viral neuraminidases preferentially hydrolyse a-2 -- 3 linkages. The 
natural substrates of neuraminidase vary widely in size and contain 
varying amounts of releasable sialic acid. Table 2.1 lists some of the 
substrates more commonly used in assaying neuraminidase. 
Neuraminidase activity is commonly determined by measuring the 
amount of sialic acid produced during the enzymatic hydrolysis of the 
appropriate substrate, usually by the thiobarbituric acid method [ 196]. 
Methods in which the released aglycone or the decrease in bound sialic 
is determined have also been described. Until today, one of the major 
setbacks in research involving neuraminidase has been the lack of a 
standard assay procedure by which all neuraminidases can be determined. 
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30. 
As a result, it has often been difficult to compare or meaningfully 
Interpret the observed properties of different neuraminidases. Thus, 
the amounts or properties determined may reflect the substrate 
specificityof the enzyme, which varies with the number of different 
linkages In the same substrate, or the limitation in the detection system, 
e. g. low sensitivity, interference, reproducibility or the differences in 
the purity of both the enzyme preparation and the substrates used. 
Often the variations obtained when measuring different sialic acid 
may relate to the nature and amounts of the sialic acids involved. For 
instance, the differences in acylation have been thought to be responsible 
for the markedly different molar extinction coefficients exhibited by 
different s ialic acids in the thiobarbituric acid test procedure [341. 
Although in the last few years methods of Increased sensitivity 
for the determination of neuraminidase activity have been described, 
e. g. byuse of natural substrates with radioactively labelled sialic 
acid moiety [ 1971 or aglycone [ 198] or by use of crystalline synthetic 
substrates of m ode defined structure [ 187] or by use of fluorimetric [ 1991 
or gas chromatographic [ 2001 techniques or by use of coupled 
enzyme systems [ 201 ] the thiobarbituric acid method [ 1961 of 
determining sialic is very widely used because of its relative sensitivity 
and convenience [ 202 ]. 
As well as finding a uniform, sensitive and specific assay for 
neuraminidase activity, current research on the enzyme has been 
concerned with its extensive purification from different origins, its 
application to molecular biological investigations and its chemical 
characterisation. Considering the wide range of sources of neuramini- 
dase in vertebrates, protozoa, bacteria and viruses, it is not surprising 
that the methods that have been adapted in its purification are quite 
different [ 33,34,45,102,187]. 
Recently, affinity chromatographic procedures based on the inter- 
action between the enzyme and either the itrhibitor, e. g. N-(p-amino- 
phenyl)oxamic acid [ 1741,4-(Nitrophenyl)oxamic acid [204], N-acetyl- 
neuraminic acid [ 205 ] or the substrate, e. g. oe1-acidglycoprotein [ 2061 , 
31. 
fetuin [31,207], colominic acid [208] have been added on to the 
conventional enzyme purification protocol as the last step. 
In spite of the great wave of research dealing with neuraminidase, 
the number of laboratories privileged to prepare neuraminidase from 
their own bacterial culture is limited, and most use the commercial 
enzyme which is not only expensive but also contains various 
contaminating activities [ 180,181,207 ] and requires further 
purification prior to use. Neuraminidases are costly to prepare by 
exisiting methods, and it is a disadvantage that they depend on the use 
of pathogens which would impose health hazards and demand elaborate 
handling techniques. Certainnon -pathogenic microorganisms have 
been found to produce neuraminidase [42,43,209] although in low 
amounts. However, non-pathogenic strains of Arthrobacter have 
recently been shown to be potent neuraminidase producers [2101. 
For the purposes of chemical characterisation of neuraminidases, 
the enzyme whichwas previously purified from a non-pathogenic strain 
of Streptomyces [ 43] was attractive. Its low molecular weight (32,000) 
and lack of subunit structures would be of particular advantage In 
interpreting chemical analyses and other studies in relative absence 
of [ntramolecular effects. Also, as a point of comparison, the 
molecular weights of several neuraminidases seem to be a multiple 
of the molecular weightof the Streptomyces enzyme (Table 2.2). 
Table 2.2 Subunit relationship of some neuraminidases 
Source of neuraminidase Molecular weight Reference 
Streptomyces griseus 32, 000 43 
Clostridium perfringens 64, 000 34 
Diplococcus pneumoniae 69, 000 34 
Vihrio cholerae 90, 000 34 
Influenze B/Lee virus 240, 000 187 
Although the molecular weights of most other neuraminidases bear no 
such relationship to the Streptomyces enzyme, it would be of interest 
to compare chemical structural data of a number of purified neuramini- 
dases. When this work was started, only the amino acid composition 
JZ, 
of influenza A2(X-7/F1) N2 neuraminidasehad been published [2111 ," 
to date three more sets of amino acid composition data of different 
neuraminidases have been added [ 187,210,2121. Also presented 
along with this data has been the carbohydrate content of neuraminidases. 
It is reasonable to assume that the variations exhibited in the 
structural comppnents of these enzymes reflect on the physical and 
functional properties of different neuraminidases. 
In this chapter the isolation, purification and characterisation of a 
neuraminidase from Streptomyces griseus will be described. Chemical 
studies on the active sites of this and neuraminidases of other origin 
will be reporte 4 to Chapter 3. 
2.2 Isolation_ purification and characterisation of a neuraminidase 
from Streptomycesgriseus 
Experimental Procedure* 
2.2.1 Growth of Strentojyces gr ise 
Streptomyces griseus MB395-A5 was grown at 27° C as previously 
described [43] except that o -acid glycoprotein (or fetuin) was also 
included In the culture medium to increase the yield of neuraminidase 
by induction [40]. The medium used had the following composition: - 
glucose, 10.0 g; starch, 10.0 g; peptone, 7.5 g; meat extract 7.5 g; 
NaC1,3.0 g; MgSO4.7H20,1.0g; K2HPO4,1.0 g; CuSO4.5H20,7.0 mg; 
FeSO4.7H20,1.0 mg; MnC12.4H20,8.0 mg; ZnSO4.7H20,2.0 mg; 
01, -acid glycoprotein, 10.0 mg (or fetuin, 15.0 mg) and water, I litre. 
The media were sterilised by autoclaving at 15 psi for 30 minutes. For 
enzyme isolation, 20 litre flasks containing 17 litres of medium were 
inoculated with cells (100 ml) from a 70-hours-old culture that had been 
started from a loop of cells from an agar slant culture. After 72 hours 
of growth at 270 C. In a well-aerated culture medium, the culture fluid 
was harvested by filtration through a celite bed at 
4 C; the filtrate 
containing the crude neuraminidase was used to purify the enzyme. 
In studies to correlate the secretion of neuraminidase with the 
growth of Streptomyces griseus, one litre Erlenmeyer flasks, each 
containing 500 ml of the medium used above, were inoculated with a 
*Unless 
otherwise stated, the sources of the special materials used are 
alphabetically listed in Appendix 1V. 
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cell growth suspension (5 ml) from a 70-hours -old culture prepared 
as above. The flasks were shaken at 27 C and 10 ml samples were 
aseptically extracted from the growth medium at different times 
and used to measure the cell growth (nephelometrically) and the 
corresponding amount of neuraminidase. 
A fully grown culture of Streptomyces griseus was a yellowish, 
light brown colour and hada characteristic 'soily' smell. The cells 
formed white balls the size of which depended on the aeration conditions. 
Faster aeration (bubbling or shaking) of the culture produced bigger 
balls; branched, thread-like structures were visible in cultures which 
were not aerated. However, the relationship between the degree of 
aeration and the amount of enzyme produced in the culture fluid was 
not studied. Microscopic examination of the growth culture revealed 
filamentous structure of branching mycelia (Fig. 2.2 ). 
Fig. 2.2 Phase contrast photomicrograph of a 72 -hours -old culture of 
Streptomyces griseus MB395-AS. Magnification: x 220. 
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2.2.2 Assay of neuraminidase in the culture fluid 
The assay ofneuraminidase activity by determining the sialic acid 
released enzyrn tally from various substrates using the thiobarbituric 
acid method of Warren [ 196] is complicated when dealing with 
biological materials because of substances such as deoxyribose and 
related materials which yield an interfering colour product [ 196,214]. In 
such samples the interfering colour product is often so intense that the 
colour changes due to small differences in sialic acid content can be 
missed altogether. In the present studies, a gel filtration column was 
introduced to separate the enzyme and other high molecular weight 
substances from the smaller sugar molecules, which interfere in the 
thiobarbituric acid test before the enzyme was assayed. The culture 
fluid (20 ml) to be assayed was passed through a Sephadex G. 25 
column (1.5 x 20 cm) previously equilibrated with 0.05 M sodium 
acetate buffer, pH 5.3, at 40 C and eluted with the same buffer. The 
fraction contained In the void volume was assayed for neuraminidase 
activity as follows: fetuin (prepared from foetal calf serum according 
to the procedure of Spiro [ 214 ])or a1-acid glycoprotein were freshly 
dissolved in 6.05 M sodium acetate buffer, pH 5.3, at a concentration 
of 4 mg/ml and used as the substrates. The reaction mixtures 
contained the substrate (0.8 ml), buffer (0.2 ml) and the culture fluid 
(1.0 ml) and were incubated for 60 minutes at 370 C before conducting 
the thlobarbituric acid assay for the free slalic acid released by the 
neuraminidase in the culture fluid. Of the different ways employed to 
stop the enzyme reaction in the assays, e. g. by heating the incubation 
mixture to 1000 C or adding protein precipitants, it has been found that 
the periodate reagent in 9M phosphoric acid comprising the first 
reagent added in the thiobarbituric acid test is sufficient and convenient 
in stopping the enzyme reaction. In the blanks, the culture fluid or 
the substrate volumes in the tests were replaced by appropriate 
volumes of buffer (Eo and So respectively). The optical density readings 
at 549 nm and the absorption spectra of the resulting chromogens after 
extraction in cyclohexanone were determined and compared with those of 
crystalline N-acetyl neuraminic acid as the standard and those obtained 
for culture filtrates prior to the gel filtration step. The absorption 
35. 
spectra, of whicha typicalexample is shown in Fig. 2.3, were 
determined by individual readings at each wavelength. 
0.2 
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Figure 2.3 Absorption spectra of chromogens obtained in the thio- 
barbituric acid assay for sialic acid. Culture fluid assayed 
for Nase (a) prior to &(b) after the gel filtration step ; 
(c) N-acetylneuraminic acid ; (d) culture fluid without 
substrate (So); (e) substrate without culture fluid (Eo ). 
The protein concentration in the culture fluid was determined according 
to Lowry et al. [ 2151. Fig. 2.4 shows the production of neuraminidase 
during the growth of Streptomyces griseus MB395-A5. 
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Figure 2.4 Production of neuraminidase during the growth of 
Streptomyces griseus M8395-A5. 
(-k ---i cell growth measured nephelometrically. 
(---ý---ý--ý neuraminidase activity units per ml cel i, 
culture fluid. AA or FA induction by 
al-acid glycoprotein or fetuin respectively. 
NI, no inducer added. 
In only two sets of studies, the enzyme was induced by fetuin 
instead of a-acid glycoprotein. The fetuin-Induced neuraminidase 
released slalic acid from fetuin much faster than did the al-acid 
glycoprotein induced neuraminidase (Table 2.3). 
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Table 2.3 
Culture fluid Units neuraminidase/ml using as substrate 
a, -acid glycoprotein fetuin 
Without inducer 0.013 0.016 
With a1-acid glycoprote in 0.054 0.032 
With fetuin 0.029 0.041 
2.2.3 Purification of neuraminidase from the culture filtrate 
The crude enzyme from the culture filtrate of Streptomyces griseus 
was purified by a combination of precipitation (with ammonium sulphate 
ion -exchange chromatography (on DEAF - and CM-celluloses ), adsorption 
on hydroxylapatite and gel filtration on Sephadex G-100 [431. All 
purification procedures were carried out at 40C. Table 2.5 summarises 
the purification procedure. To assay fractions other than the culture 
fluidfor neuraminidase activity, a2 mg/ml solution of fetuln or a! 1-acid 
glycoprotein in 0.05 M sodium acetate buffer, pH 5.3, was used as the 
substrate (0.5 ml) and incubated with the enzyme fraction (0.5 ml) for 
50 minutes before conducting the Warren assays for the released sialic 
acid [ 1961. Protein concentration was determined according to Lowry 
et al. [ 215 ]. 
Furtherpurification was afforded by a final affinity chromatographic 
step using fetuln bound to cyanogen bromide-activated sepharose [31 ]. 
Sepharose 4Bwas activated with cyanogen bromide as described by 
March et al. [ 2161 and the activated agarose was then coupled to fetuin 
as described in the method of Scheid and Choppin [ 311. The resulting 
fetuin-Sepharose was stored in aqueous suspension with 0.02J, sodium 
azide at 40 C until used. To assess the stability and effectiveness as 
adsorbent for neuraminidase of fetuin -sepharose in affinity chromato- 
graphy, its sialic acid content was determined by the method of Warren 
[ 1961 after release with neuramin idase incubation at 370 C for 2 hours 
or after hydrolysis in 0.125 NH 2504 at 800 C for 1 hour [ 2031. 
These determinations were done on 1.0 ml settled predialysed fetuin- 
Sepharose; the neuraminidase incubations were done with 2 mg of 
38. 
Clostridium perfringens neuraminidase. The sialic acid content 
determined, using crystalline N-acetyl neuraminic acid as the 
standard, is tabulated (Table 2.4). 
Table 2.4 Sialic acid content of fetuin-sepharose 
Substrate Total moles sialic acid released by 
Neuraminidase Acid hydrolysis 
Fetuin (18 mg used to couple 4.3 4.9 
1.0 ml sepharose) 
Fetu in -sepharose (1. Oml) 2.1 3.7 
The results Indicate that only 60% of the fetuin involved in the coupling 
reaction is actually attached to sepharose; further, the value of the 
sialic acid content of fetuin -sepharose as obtained after neuraminidase 
treatment differs from that obtained after acid hydrolysis. The higher 
value obtained In acid hydrolysis may possibly be due to agarose 
hydrolysis products interfering in the Warren assay, while the lower 
value obtained after neuraminidase treatment may be due to steric 
hindrance of fetuin-sepharose with the enzyme. 
Affinity chromatography of S. gris_ej neuramin idase on f ruin -sepharose 
Affinity chromatography was accomplished at 40C on a column 
(1.5 x 20 cm) of fetuin -sepharose equilibrated with 0.05 M sodium 
acetate byffer, pH 5.3. Neuraminidase fraction VI (Fig. 2.5A, Table 
2.5) obtained from active fractions after gel filtration on Sephadex 
G-100 was concentrated by ultrafiltration with a PM-10 membrane and 
buffer 
dialysed against 0.05 M sodium acetate 4 p1H 5.3, before application on 
to the affinity column. The column was washed with the equilibration 
buffer until the protein concentration, determined by the method of 
Lowry et al. [215]was less than 5 µglrnl (point E, Fig. 2.5B). The 
bound neuarminldase was then elutedwith 0.1 M sodium borate buffer, 
pH 8.5, containing 0.1 MKC1 [206]. The effluent fractions containing 
neuraminidase were pooled and concentrated by ultrafiltration as above, 
dialysed against 0.05 M sodium acetate buffer, pH 5.3, and stored as 
such, or freeze-dried, at -150 C until used. 
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Fig. 2.5 A. Gel filtration on Sephadex G-100 according to Kunimoto et al. 
[431 toproduce fraction VI. B. Affinity chromatography on a 
fetuin-sepharose column as described above. Fraction VI was 
concentrated to 2.0 ml and applied on the column. Elution was 
carried out with 0.05 M sodium acetate, pH 5.3, until point E, when 
0.1 M sodium borate buffer, pH 8.5. was used to elute the enzyme. 
(-o-o ) protein concentration (mg/ml )[ 2151; (---t-. -) neura- 
minidase activity (µmoles) sialic acid released/0. I ml); 
(-x-x-) protease activity (moles bonds cleaved/0.1 ml)[217]. 
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2.2.4 Enzyme purity 
Protease assay: The method of Lin et at. [ 2171 was used to determine 
protease activity in the enzyme fractions obtained after gel filtration 
(fraction VI) and after the final affinity chromatography step (fraction 
VII). No protease activity was detected in fraction VII (Figure 2.5). 
Detection of protease activity by an electrophoretic method 
An attempt was made to develop a method In which the Intensity 
of a protein band appearing after its electrophoretic run would 
reflect on the degree of proteolytic activity to which it was subjected 
before electrophoresis. Thus, to detect proteolytic contaminants in 
neuraminidase preparations, the different neuraminidase fractions 
were each incubated with the same amount of a protein of known 
purity at 370 C for various times, after which the samples were 
analysed electrophoretically on 7.5% polyacrylamide gels using the 
method of Weber and Osborn [ 218] (Figure 2.6). 
From these studies neuraminidase fraction VII was judged free 
of proteolytic contaminants. Vhile this work was in progress, this 
Idea of detection of proteolytic activity was applied by other workers 
[220] In peptide mapping studies. 
Analytical gel electrophoresis 
Further demonstration of purity of neuraminidase was achieved 
by electrophoresis on 7.5% polyacrylamide-SDS* gels which were 
prepared and run as described by Weber and Osborn [218] (Figure 2.7) 
Neuraminidase ran as one single band. 
2.2.5 Character isation of Streptomycesgriscus neuraminidase 
2.2.5.1 Molecular weight determination 
(a) The molecular weight of neuraminidase was estimated by gel 
filtration on a Sephadex G-100 column (2.2 x 50 cm) following the 
procedure of Andrews [ 2211. The column was calibrated with five 
proteins of known molecular weight. Two milligrams of each of these 
proteins (1.0 mg neuraminidase) was dissolved in 2.0 ml of 0.1% blue 
sodium dodecyl sulphate 
42. 
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Figure 2.6 Electrophoretic detection of proteolytic contaminants in 
neuraminidase preparations. The incubation mixtures 
consisted of 25 µl of test solution and 60 ýtg carbonic 
anhydrase in 80 pI of 0.1 ivl phosphate buffer, pH 7.4 
[219]. The bands shown were stained for protein with 
Coomassie Blue. 
(a) tryps in (20 µg/ml) incubated for 24 hours 
(b) trypsin incubated for 12 hours 
(c) neuraminidase fraction VI (Table 2.5) incubated for 24 hours 
(d) neuraminidase fraction VI (Table 2.5) incubated for 12 hours 
(e) neuraminidase fraction VII (Table 2.5) incubated for 24 hours 
(f) neuraminidase fraction VII (Table 2.5) incubated for 12 hours 
(g) control containing 25 wl of buffer instead of test solution 
incubated for 24 hours 
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Figure 2.7 Polyacrylamide gel electrophoresis of the neuraminidase 
purified by affinity chromatography on fetuin -sepharose. 
dextran and the solution was slowly eluted from the colurm with 0.2 M 
phosphate buffer, pH 7.0, containing 0.05 M KCI at a rate of 40 
ml/hour, collecting 4.0 ml fractions. The elution volume of each 
protein was determined by monitoring the absorbance of the eluted 
fraction at 280nm. The elution peak of neuraminidase was identified 
by its enzyme activity (Figure 2.8). 
(b) The molecular weight of 7 eil neuraminidase was also 
estimated by SDS-polyacrylamide gel electrophoresis, employing the 
method of Weber and Osborn [2181. The B. D. H; ` molecular weight 
markers comprisinga mixture of oligomers of molecular weights in 
the range 14,300-71,500 were used as described by the manufacturers 
[222]along with 15 µgof purified neuram lnidase. After the electro- 
phoretic run, the gels were stained with Coomassie blue and destained 
by diffusion [ 218](Figure 2.9 ). 
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Figure 2.8 Gel filtration of purified S. griseus neuraminidase 
on a Sephadex G-100 column (2.2 x 50 cm). 
The molecular weight determined from gel filtration was 
32,000 while that obtained from electrophoresis was 31,600. 
A value of 34,000 was kindly estimated by Dr. I. Kennedy after 
ultracentrifuge sedimentation of the purified neuraminidase 
on a sucrose gradient. 
Table 2.6 Molecular weight determination of 
neuramiin i. dase bV electro horesis 
Band M. Wt log Distance Electro- 
M. 1Wt band from phoretic 
start (cm) mom 
Ref. Brom -- 14.6 100 
it 
'henol blue 
a 14,300 4.15 13.1 89.7 
b 28600 4.45 9.5 65.1 
c 42900 4.63 6.9 47.3 
d 57200 4.76 5.1 34.9 
e 71 500 4.85 4.0 27.4 
f 85 800 4.93 3.0 20.5 
, 
N 31t23 4,5 9. C ý', _ 
4. 
4. 
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Figure 2.9 Determination of the molecular weight of S. griseus 
neuraminidase bySDS-polyacrylamide gel electro- 
phoresis. a-f correspond to the bands whose molecular 
weights are shown in the table (Table 2.6). 
N- neuraminidase. 
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(c) Electrophoresis of neuraminidase in non-denaturing conditions. 
Electrophoresis of purified S. griseus neuraminidase was carried 
out employing the method described by Gabriel [ 2231. Neuraminidase 
(previously dialysed against 0.05 M Tris -phosphate buffer, pH 7) 
was applied asa sample (containing 200 4g in 100 wl of dialysis buffer 
and 0.0002% methylene blue) and run on a cylindrical 7.57, poly- 
acrylamide gel (0.5 x 10cm ) using a current of 1.5 mA per tube. 
The electrophoresis was conducted at 40 C, after which the gels were 
longitudinally sliced and stained for protein [ 2181 or neuramin idase 
activity [2241. The staining for neuraminidase activity using 
2, (3' -methoxyphenyl )-a1-N-acetylneuraminic acid (MPN) and Black K 
salt (a diazonlum salt of 4-amino-2,5-dimethoxy-4-nitroazobenzene) 
was not successful, but one of the 0.50 cm transverse sections of 
the gel, corresponding totheprotein stained band, showed neuramini- 
dase activity after eluting the enzyme from it with 0.05 M sodium 
acetate buffer, pH 5.3, and assaying the eluted enzyme with fetuin 
as described earlier. Neuraminidase travelled about 3.5 cm on 
the separation gel. 
2.2.5.2 Chemical analysis of S. griseus neuraminidase 
(a) N-terminal analysis 
The N-terminal amino acid was determined following the 
procedure of Gray [2251. After oxidation with performic acid, neura- 
minidase (0.3 mg) was dissolved in 50 µl 1T SDS in a small pyrex test 
tube and 50 µl N-ethylmorpholine was added. A freshly made solution of 
dansylchloride (25 mg/ml, 75 µl) in anhydrous dimethyl formamide 
was added and mixed; the reaction was allowed to proceed at room 
temperature for 3 hours after which the labelled enzyme was 
precipitated by adding acetone (0.6 ml) to the reaction mixture. 
The resulting precipitate was compressed by centrifugation, washed 
with 80%acetone (500 µl), centrifuged again, dried by evaporation 
in vacuo and hydrolysed with 6N HCI (150 wl) at 1100 C for 18 
hours. The resulting dansyl amino acids were identified chromato- 
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graphically by comparison with dansyl amino acid markers on 
polyamide layer sheets employing the solvent systems of Hartley 
[226]. The dansylated amino acids were visualised under ultra- 
violet light and the position of the spot corresponding to the dansyl 
alanine marker coincided with that of a spot arising from the 
hydrolytic products of the dansylated neuraminidase. Alanine was 
therefore judged tobe the N-terminal amino acid in this enzyme. 
(b) Amino acid and sugar analysis* 
Amino acid analyses of the purified neuraminidase from Strepto - 
myces griseus were done on a Locarte automatic acid analyser; 
neutral sugars were analysed ona Jeo1JLC-6AH sugar analyser. 
The values for the amino acid content of neuraminidase are given 
in Table 2.7 and are the mean of four determinations, based . on the 
molecular weight of 32,000. 
Table 2.7 Amino acid content of S. griseus neuram[nidase 
Amino 
acid 
Asp Thr Ser Glu Pro Gly Ala Cys 
No. 23.3 17.3 17.9 38.6 38.6 39.7 21.1 1.3 
residues 
Amino Val Met Ileu Leu Tyr Phe His Lys Arg 
acid 
No. 
residues 
18.9 5.4 12.4 19.3 7.0 8.3 9.0 17.3 9.9 
The value for tryptophan was not determined; however, Augustus [2271, 
working on the same enzyme, has reported a maximum of 2 residues. 
In the neutral sugar analysis, mannose, galactose, xylose, fucose, 
fructose and arabinose were detected in trace amounts. In contrast, 
the glucose content was about 20 residues per molecule of neuraminidase. 
Since only two determinations were made, these values are not 
conclusive. The high value of glucose may have been derived from the 
chromatographic supports employed in the course of enzyme 
*purifi'cation. Further acidic and basic sugars were not determined. Amino acid and sugar content was determined"by Dr. J. E. Fox, 
Macromolecular Analysis Service, Birmingham University. 
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(c) Determination of disulphide links in S_ 1s_cjW neuraminidase 
The method of Cavallini et al. [ 2281 using sodium borohydride in 
8 molar urea as the reducing agent and 5,5' -dithiobis(2-nitrobenzoic ) 
acid (DTNB) as a thiol disulphide exchanger was used to estimate 
the total number of sulphydryl groups in neuraminidase. Fig. 2.10 
shows the titration of sulphydrylgroups in different amounts of the 
enzyme. 
COO- coO COO O 
NO S -LS NOZ Protein ý-S NO2+ S-=( 
Prote In -S O 
S0 
In the reaction at pH 8. anionic forms of protein thiol groups attack the 
disulphide bond of the DTNB reagent expelling a stable-coloured 
nitrothiophenolate anion whichmay be estimated spectrophotometrical ly 
at 412 nm. 
0.066 
E 0.0 
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Fig. 2.10 Determination of disulphide groups in neuraminidase 
with DTNB. 
4), 
The number of total sulphydryl groups after reduction is given 
by the formula 
N 
M. wt. xA xV 
12,000 xm 
where M. wt. is the molecular weight of the enzyme (32,000 in this 
case); A Is the optical density value obtained at 412 nm in the method; 
V is the volume of the final solution (6.0 ml) and m is the weight 
(mg) of the enzyme sample analysed. The figure 12,000 is the 
molar extinction coefficient of the ni troth i opheno I ate anion. 
N_ 
32 000xOx A 
12,000 m 
( m) is the slope of the graph (Fig. 2.11 )relating values of A and 
the weight of neuraminidase, In this case (m) _ 
0.030 
0.275, 
0.030 32 000 x6''N=0.275 
12ý 000 = 1.82 
This number of sulphydryl groups, however, includes the pre- 
existing sulphydryl groups. 
(d) Determination of sulphydryl groups in S_ griseus neuraminidase 
The technique for the quantitative determination of sulphydryl 
groups in proteins developed by Rohrbach et al. [ 2291 using 4,4-bis - 
dimethylaminQphenyl carbinol (BDC-OH) was applied on neuraminidase. 
Neuramintdase (1.6 mg) was dissolved in 1*. 0 ml 0.04 M sodium 
acetate buffer, pH S. 1, containing 4M guanidine hydrochloride. 
Aliquots of 50,100 150,200 and 250 µl of this solution were 
separately mixed with 100 41 of 0.65 mg/ml solution of BDC-OH in 
acetone and the mixture was made up to 5.0 ml with acetate buffer. 
After 30 mins the absorbance of each solution was determined at 
612 nm (Fig. 2.11 ). 
4.4'-bis -dimethylam inophenyl carbinol (BDC-OH) was synthesised 
by L. Carr following the method reported by Rohrbach et al. [ 2291. 
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Fig. 2.11 Determination of sulphydryl groups in neuraminidase 
Number of sulphydryl groups = -slope (where Em is the molar Em 
extinction coefficient of the reacted BDC-OH = 70P 800 M-1cm-1 
.. the number of sulphydryl groups = 70.800 x 17.5 x 10-6 
= 1.29 
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(e) Demonstration of glycoprotein nature of Sjgriseus neuraminidase 
Two methods of staining glycoproteins were used to detect 
carbohydrate in protein bands corresponding toneuraminidase after 
gel electrophoresis. The periodic -acid-Schiff (PAS) procedure of 
Kapitany and Zebrowski [230] and the sensitive fluorescent staining 
method of Eckhardt et al. [ 2311 were used. A device of olxainIng 
longitudinal slices of cylindrical polyacrylamide gels was designed 
to permit easier comparison of the protein-acid carbohydrate -stained 
bands on gels. This device is described in Appendix 3; here it will 
suffice to ment ton that thedevice obviates the necessity to run two 
samples (to be stained differently) or to employ other methods which 
lack precision, e. g. slicing witha scalpel or wire. 
After electroph1sis as described earlier, the gel on which 
purified neuraminidase was run was sliced longitudinally and one 
half of the gel was stained for protein (Fig. 2.7) while the other half 
was stained for glycoprotein. Figure 2.12 shows the fluorescent band 
of neuraminldase demonstrating the glycoprotein nature of this 
enzyme. 
2.2.6 Catalytic properties of S. Izriseus neuraminidase 
The effect of enzyme concentration, time, temperature and pH on 
the activity of the purified S. griseu, s neuraminidase was studied, 
using s is lyllac tose oýl -acid glycoprotein, fetuin and mu c in as 
substrates. The effect of various metal ions andthe inhibitory effect 
of N-acetyl neuraminic acid on the enzyme activity were also 
Investigated. 
The assay mixtures consisted of the substrate solution (0.4 ml) in 
0.05 M sodium acetate buffer, pH 5.3, (1 mg/ml sialyllactose; 4 mg/ml 
CY, -acid glycoprotein; 5 mg/ml fetuin; 2 mg/ml mucin), 0.05 M sodium 
acetate buffer (0.4 ml) and neuram inidase solution (0.2m1). In blank 
incubations the enzyme solution was replaced by an equal volume of 
buffer while in studies on the inhibitory effect of N-acetyl neuraminic 
acid, MPN* (0.5 mg/ml) was used as the substrate. After appropriate 
*2- (3' -methoxyphenyl ) -d I -N -acety 
lneuram in is ac id 
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Fig. 2.12 
Neuraminidase electrophoretic 
band stained with dansyl hydra- 
zine [ 2311. The arrow shows 
the fluorescent band 
corresponding to the protein 
band of neuraminidase. 
times of incubation the released sialic from each substrate 
was determined by the thiobarbituric acid procedure [ 196] except in 
the case of MPN when the enzymic activity was followed by 
determining the released 3-methoxyphenol as described by Palese 
et al. [224] using the Folin phenol test. The results obtained in 
these studies are summarised in Figures 2.13-2.15 and Tables 2.8 and 2.9. 
The kinetic constants (Km and Vmax) of S. griseus neuraminidase 
were determined using various amounts of sialyllactose; the assay of 
the enzyme was conducted as described above. The initial rate of 
hydrolysis at each substrate concentration was determined and the 
results obtained were analysed by the method of Lineweaver and 
Burk [232] (Figure 2.17). 
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The protein concentration of neuraminidase used in the assay 
mixtures was 0.5 mg/ml. Hydrolysis of various substrates was 
carried out for different periods, after which the amount of sialic 
acid released from each substrate by incubation with neuram inidase 
at 37° C was determined by thiobarbituric acid procedure [ 196]. 
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Figure 2.13 Hydrolysis of various substrates by S. griseus 
neuraminidase. SL, sialyllactose; AA, a1-acid 
glycoprotein; Mu, mucin; Fe, fetuin. Reaction 
conditions as in text. 
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To determine the effect of metal ions on the enzyme, the assay system 
already described was used but with substrates previously exhaustively 
dialysed against 0.005 M sodium acetate buffer, pH 5.3, at 40C. The 
activity of the enzyme in the reaction mixtures supplemented with metal 
tons (Table 2.8-) was compared with the unsupplemented control; It was 
found that the substances added had no substantial effect on the 
initial rate of neuramiinidase activity except Hg2+ and Fe2+ which 
slightly inhibited the enzyme. These observations agree with those of 
Kumimoto et al. (43) for the same enzyme, but differ from the vibrio 
cholerae a the viral enzyme (33,34 187) which are dependent on metal Tabiý8 ffect of added metal ions od neuraminidase activity r...,, - 4-- 
Substance added Concentration Mx 10-3 (?,, control activityýt 
ivi ty. 
Control - 100 
CaC12 0.5 90 
MnC12 0.5 100 
CoC12 1.0 97 
MgC 12 1.0 89 
FeC12 0.5 65 
ZnC12 0.8 90 
HgC12 0.5 55 
Fe2C13 0.5 91 
When investigating the effect of temperature on S. griseus neuraminldase 
the enzyme solution (0.5 mg/ml) to be assayed was exposed to the 
temperatures shown 5 minutes ;B (Table 2.9) for various times (A 10 , , 
minutes; C 30 minu 2 hours) and then assayed as described tes; D , , , 
using fetuin as the-substrate and an incubation period of 50 minutes. 
Table 2.9 Effect of temperature on S. griseus neuraminidase 
Temperature °C 0 37 45 50 60 
%full enzymatic 
activity A 100 100 65 10 3 
B 100 95 55 3.5 0 
C 100 86 32 1.4 0 
D 100 60 15 0 0 
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To determine the effect of pH on the enzyme, the assay 
mixtures containing the substrate solution (0.5 ml), the buffer 
(0.3 m1,0.1 M sodium acetate or 0.1 M sodium phosphate) and 
enzyme solution (0.2 mg/ml, 0.2 ml) were incubated at 370 C for 
various times, after which the amount ofsialic acid released in each 
case was determined, and the corresponding enzyme rates were 
0,1 o'. 
c_ 
E 
"v a) 
cd 0) 
v 
.ý0., (ý 
cc 
U 
C) 
E 
345 
pH 
iý 
Figure 2.14 Effect of pH on reaction rate of hydrolysis of sialyl- 
lactose (SL), a'1-acid glycoprotein (AA ), fetuia (Fe) 
by S. griseus neuraminidase. pH 3-6.5 using acetate 
buffer; pH6.5-8 using phosphate buffer. 
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When studying the inhibition of S. griseus neuraminidase by 
N-acetyl neuraminic acid (NANA), the enzyme was assayed 
using 2-(3'-methoxyphenyl)-N-acetyl-o-neuraminic acid (MPN) 
and determining the released 3-methoxyphenol [224]. The 
enzyme solution (0.5 mg/ml, 0.3 ml) was incubated at 370 C 
with MPN (2 x 10-3M. 0.5 ml) and the rate of release of 3-methoxy- 
phenol in the presence of varying amounts of NANA in a total volum(m 
of 1.0 ml were determined. The rate of 3-methoxyphenol release in 
Jabsenc°e" or I1ANýi )twas taken as 100% of enzyme activity and the 
activities of the enzyme thus determined in the presence of 
NANA were expressed as % control enzyme activity (Fig. 2.15). 
u 
Co co 
E 
co 
O 
O 
u 
EýQ 
0 
90 
80 
70 
60 
0 0, 50 
0 
40 
30 
0 
20 
10 - 
0 
0 4 1 1 
Concentration of NANA (mM ) 
F. 2.15 inhibition of S. griseus neuraminidase by N-acetyl- 
neuraminic acid (NANA). The shown amounts of 
NANA were incubated with the enzyme for 5 minutes 
before the substrate (MPN) was added and the 
enzyme activity determined. 
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To determine the nature of the inhibition of S. griseus neuraminidase 
by NANA, neuraminidase (0.5 mg/ml , 
0.5 ml) and MPN (2 x 10-3 M, 
0.5 or 1.0 ml) were incubated at 370 C with varying amounts of NANA in a total 
volume of 2.0 ml. At various time intervals (starting at zero time) up to 
200 µl were withdrawn and the amount of 3-methoxyphenol produced 
was Immediately determined. A rate -curve was- thus, obtained i for each 
NANA concentration and for both levels of substrate concentration. The 
results obtained were p4o-Eted according to Dixon (240) (Figure 2.16). 
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E la. 2.16 Dixon plot for the determination of the type of S. griseus 
neuraminidase inhibition by NANA. The values on the 1/V axis are 
reciprocals of the amounts of 3-methoxyphenol released per unit time 
n entration. NANIk / (_f .)0.5 ml ý 
(O-) 1.0 ml of MPN solution. A value 
of -4.0 mM was estimated for Kip the inhibitory constant. 
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S. griseus neuraminidase (0.5 mg/ml, 0.2 ml) was incubated 
with varying amounts of sialyllactose in a total volume of 1.0 ml 
[ 
"j 
mM-1 x 10-2 
Figure 2.17 Determination of Km and Vmax of S. griseus 
neuraminidase; using sialyllactose, these values 
were respectively 1.8 x 10-4 M and 0.021 ' 1j, moles 
N-acetylneuraminic acid per µg enzyme protein. 
and for each concentration of slalyllactose used, the initial 
rate of neuraminidase reaction was determined and the results 
thus obtained were analysed according to the method of Lineweaver 
and Burk (232) (Figure 2.17). 
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2.2.7 Discussion 
As mentioned earlier, the more potent neu ram in Ida se. producers VS. &. 
Clostridium perfringeisVibrio cholerae are known pathogens; the 
pathogenicity of Streptomyces griseus has not been reported in 
man. However, Streptomyces have been known to cause pneumonia 
in buffaloes [ 2331 and some strains have been shown to produce a 
volatile substance which kills fungi [ 2341. It is also noteworthy 
that some species of Streptomyces produce a specific inhibitor of 
viral neuraminidases (called neuraminin) which is without effect 
on bacterial neuramInidases [ 235 ]. 
The production and induction of neuraminidase in several species 
of Streptomyces has been reported [ 41,43,213 ]. In the present 
studies neuraminidase was produced from S. griseus by induction. Over 
4 times more neuraminidase was produced with than without 
added Inducer. Neuraminidase appeared in the culture fluid in 
amounts corresponding to the increase in cell mass; the enzyme 
activity started decreasing when the maximum point of growth 
(after about 72 hours) was reached. There was a slight increase In 
the extent of growth (related to cell number) in the Induced over the 
non-induced cultures (Figure 2.4), lxit it Is difficult to judge whether 
the greater production of neuraminidase in induced cultures was a 
result of an increase in cell number or due to actual induction of the 
enzyme. 
More neuraminidase was produced when a1-acid glycoprotein 
(rather than fetuin) was used as an inducer. This may be attributed 
to the higher sialic acid content of the former and also possibly to 
the presence of multiple glycosidic linkages, some of which are 
resistant toneuraminidase, and thus favour thepersistence of 
a, -acid glycoprotein in solution as an inducer. It was interesting to 
note that the fetuin -induced neuraminidase released sialic acid from 
fetuin much faster than the a, -acid glycoprotein induced enzyme or 
the enzyme produced from non -induced cultures. Although these 
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observations were not repeated in Induction studies other than the 
two reported above, the possibility of inducing neuraminidase 
specifically Is interesting. It would be possible to study the apparent 
lack of specificity exhibited by neuraminidases in cleaving (even If 
at different rares) mostpossible glycosidic linkages of sialic acid 
to its natural partners. However, these results are in contrast to 
the work of Uchida et al. [ 41 ] in which the neuraminidases induced 
by colominic acid (a homopolymer of sialic acid with a, 2--8 
linkages) in several bacteria including Streptomyces were shown to 
possess wider substrate specificities. 
The gel filtration method introduced to remove low molecular 
weight substances which interfere in the thiobarbituric acid test for 
the released sialic acid also served to remove substances such as 
carbohydrates which react with the Lowry reagent in the same manner 
as proteins [2361. The use of both substrate and enzyme blanks (So 
and E0 respectively in assaying neuraminidase in culture fluids 
further served to exclude interference from the contaminants 
remaining after the gel filtration step. Nevertheless, the values for 
neuraminidase content obtained were often not reproducible; as well 
as inconsistencies in the assay procedure, the cultures of S. griseus 
may have somehow varied in their ability to produce the enzyme. 
substances 
Various other methods have been used to exclude interfering / 
in the assay for neuram inidase, especially in crude biological 
materials. Srivastava andAbou-Issa [237] added ammonium pyrroli- 
dine dithiocarbamate before the per iodate oxidation step in order to 
eliminate chromogen formation due to reactive uncleaved sialic acid 
from glycoproteins,, but the mechanism by which this is done is not 
known. Recently Sauter [238] described a new method of measuring 
neuraminidase activity by reacting the enzymatically released 
aglyconefrom 2-(3-methoxyphenyl)-cr-D-neuraminic acid with amino- 
antipyrene in the presence of potassium ferricyanide to yield .a 
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coloured complex (Em = 11,000). Although this method shows 
great promise of use on account of its simplicity and rapidity, it is 
not more sensitive than the Warren assay (En=57,000), besides, since 
the colour development depends on the effect of an oxidising agent, it 
would be subject to interference from indigenous reducing or 
oxidising agents In biological samples. The other methods of assaying 
neuraminidase (mentioned at the beginning of this chapter) are also 
limited in use because, although they are more sensitive than the 
Warren assay, they require additional procedures such as column 
chromatography or dialysis, or depend on substrates which are not 
available commercially or demand elaborate and expensive 
equipment . 
The neuraminidase produced by S. griseus was purified to homo- 
geneity. The enzyme ran as a. single band on SDS-polyacrylamide 
gel electrophoresis and did not contain any contaminating proteases. 
Treatment of the polyacrylamide gel, after electrophoresis of 
neuraminidase, with periodate/dansyl hydrazine or per iodate/Schiff's 
reagent detected a carbohydrate band coincident with the protein- 
stained band of neuram inidase, and together with the results of the 
sugar analysis indicated that this enzyme is a glycoprotein. 
A molecular weight of 31,600 was assigned to the enzyme by 
electrophoretic analysis while 32,000 was the value estimated by 
gel filtration and 34,000 was determined by ultracentrifugation. All 
these values of molecular weights are close to the range of 31,000- 
33,000 determined by Kunimoto et al. [43] by gel filtration; further, 
their concordance would suggest that the enzyme is a single poly- 
peptide. However, because of the glycoprotein nature of the enzyme, 
these values may be anomalously higher than their real values as 
would. be expected for polypeptides of the same size [221,239]. 
From the amino acid analysis, the rather high content of serine and 
threonine (together constituting 12.67 of the amino acid residues) may 
be relevant to the glycoprotein nature of the enzyme. Other neura- 
minidases [210 2121 also possess high amounts of serine and 
threonine and have been shown to be glycoproteins. 
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The acidic residues (22%) outnumber the basic ones (12%%). This 
Is also truewith other neuraminidases whose amino acid content is 
known [ 1871,210,212]. However, in the case of S. griseus neuramini- 
dase this property neither is consistent with the enzyme's failure to 
bind to a DEAE -cellulose column at pH 6 while it binds fairly tightly 
to a CM-cellulose column at pH 5.3, nor does it explain the high 
Isoelectric point of 7.9-8 determined by Kunimoto et al. [ 43]. 
However, In the study (reported above) in which the electrophoresis 
of this neuraminidase was run in the absence of SDS in non -dissociating 
conditions at pH 7.0, the enzyme behaved as a negatively charged 
protein and migrated to the anode. This would suggest that the iso- 
electric point of the enzyme is at least below pH 7.0 since proteins 
are negatively charged at pH's above the it isoelectric point. Again, 
the anomalous behaviour of glycoproteins in these studies or the nature 
and content of the basic and acidic sugars (which were not determined) 
may be responsible for the inconsistencies observed. The high 
dicarboxylic acid content would justify the use of ahydroxylapatite 
column In the purification of the enzyme. The enzyme has very low 
content of sulphur-containing amino acids, and the observed lack of 
effect by p-chloromercuribenzoate [ 431 on the enzyme activity is not 
surprising. The number of sulphydryl groups estimated by chemical 
means agrees with the values obtained by amino acid analysis. The higher 
value of 1.82 obtained using DTNB after perform is acid 
oxidation In comparison with that of 1.29 obtained with 
BDC-OH would imply that the enzyme possesses either one disulphide 
bond and one free cysteine or that it contains just two cysteines , one of 
which has buried residues and is unreactivewith BDC-OH. The high 
content of proline is suggestive of little helical structure for the 
S. griseus neuraminidase. The amino-terminal amino acid was easily 
detected as alanineby the dansyl chloride procedure, and is probably 
exposed. The detection of only one dansylated amino acid further 
reflects on the purity of this enzyme preparation. 
From the kinetic studies on the enzyme, it is apparent that thepH 
optimum (average 5.3) of S. griseus neuraminidase is dependent on the 
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substrate used. The shape of the pH curve is suggestive of the 
existence of lonlsable groups in or close to the active site of the 
enzyme and the fact that the enzyme activity falls off on either side 
of the pH otpimum would indicate that the active state of the enzyme 
is an intermediate form. On the question of pH, it is interesting that 
despite the reported differences in the catalytic pH optima of neura- 
minidases from different sources (Vibrio cholerae, Clostridium 
perfringens and &fluenza virus) [33,341, the optimum pH for adsorption 
to the affinity column of Cuatrecasas and Iliano [ 1741 was aboutpH 5.5 
for all the three different neuraminidases. 
The Km value of 1.8 x 10-4 "M for sialyllactose obtained in the 
present study is quite close to the values reported for other neura- 
minidases [ 33,34] but is slightly lower than the value of 4x 10-4 M 
obtained by Kunimoto et al. [43] for the same enzyme. From the Dixon 
plot (Figure 2.16). NANA behaves as a competitive Inhibitor of S. griseus 
neuraminidase, and in this respect this enzyme Is similar to Vibrio 
cholerae and viral neuraminidase but different from the enzyme from 
Clostridium perfringens which is not significantly inhibited by NANA 
[33,102]. The neuraminidase from an Arthrobacter species, described 
by Wang et al., [ 210] is also Insensitive to inhibition by NANA. The KI of 
of NANA for S. griseus neuraminidase was about 4x 10-3 M for MPN 
beingabout 20 times more than the Km ' and therefore making 
NANA a 
ratherweak Inhibitor of S. griseus neuraminidase. 
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Chapter 3 
3. Mechanism of Neuraminidase Action 
3.1 Introduction 
"It is quite natural that enzyme chemists have, thus far, been 
occupied with the, discovery of many kinds of enzymes, the ingenious 
methods of preparing them and the measurement of their activity. 
But atthis point we must enquire into the chemical mechanisms by 
which they work". L. Michaelis, 1946 
The overall catalytic function of an enzyme may be attributed to a 
combination of the processes of substrate binding, the substrate 
specificity of the enzyme and the catalytic process itself. Although 
many compounds may bind to an enzyme, only certain types (substrates ) 
lead to subsequent chemical reaction, while other types may affect the 
overall rate of arl enzymic reaction in a positive (activatory) or 
negative (inhibitory) way. Generally, the molecular mechanisms which 
define the binding, specificity or catalytic activity of an enzyme depend 
on the enzyme's three-dimensional structure in solution. The crucial 
specific region on or near the enzyme surface encompassing all the 
amino acid chains that individually or in concert participate in binding 
the substrate to the enzyme and in performing the catalytic proces has 
been termed the enzyme's 'active site'. 
Alteration of these amino acid residues by physical or chemical means 
can contribute to an understanding of the chemical events by which they 
direct the catalytic function of an enzyme, and their identity constitutes 
a primary requirement for such an understanding. In addition . 
information 
on the structure and conformation of the active sites in an enzyme can be 
gained through studying the interaction of the enzyme with chemically 
modified substrates or inhibitors. 
In the case of neuraminidase, important information regarding the 
action of the enzyme has been obtained through the modification of the 
the sialic acid moelty,, or the aglycone to which it is attached, in 
neuraminidase susceptible substrates. Examination of neuraminidase It 
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substrates reveals four functional groupings: the carboxyl, the hydroxy 
chain, the acylated amino nitrogen and the aglycone (Figure 2.1)(page 28). 
Schauer and Faillard [ 2411 have reported that o-ketos ides of 
7-0-acetyl-8-0-acetyl and 7,8-0-diacetyl-N-acetyl neuraminic acid 
are cleaved by neuraminidase at a slower rate than the corresponding 
compounds with unsubstituted hydroxyl groups; whereas these results 
would indicate that a substitution of the hydroxyl groups in the poly- 
hydroxy side chain of slalic acid is possible with only slight effect on 
the affinity of the enzyme for the substrate, the observed reduced 
inhibitory capacity of N-acetylneuraminlc acid bearing bulky 
substituents In the polyhydroxy side chain (e. g. lipophilic cyclic acetals 
of N-acetylneuraminic acid : 7,9-0-benzylideneor 7,9-0-. ethylidene 
derivatives of N-acetylneuraminic acid [2421 (Figure 3.1 ) could 
possibly also be interpreted in terms of the size of the space in the 
enzyme available for the polyhydroxy chi in of the substrate. 
CH3 
CH 
OH II 
CH2-CH -C: 
A 
OH 
A 
i 
O OH O 
J CH2 CH- 'OH 
ACI, 1H '" / 'OH 
SOH 
OH 
OH 
Fig. 3.1 A. 7,9-0-ethylidene-N-acetylneuraminic acid. 
B. 7.9-0-benzylidene-N-acetylneuraminic acid. 
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Further, a negatively charged group (e. g. carboxyl) in the hydroxy chain 
of the substrate renders it resistant to neuraminidase [ 2421 . while 
the 
shortening of the hydroxychain of sialic acid by periodate oxidation 
followed by borohydride reduction greatly reduces the susceptibility of 
the substrate to both bacterial and viral neuraminidase action [243]. 
N-acetyl-4-acetylneuraminic acidglycosides, such as are present in 
mucin, are resistant to bacterial neuraminidases [244]. 
The action of neuraminidase has been reported to vary with the nature 
of theN-substituent. The exchange of the N-acetyl (CH3CO-) group in 
the substrate for an N-prop[onyl (CH3CH2CO-) N-formyl (HCO-) or 
N-glycolyl (CH2OH-CO-) group reduces the rate of the enzymatic 
hydrolysis of the ci-ketos[dic bond, while replacement of the N-acetyl 
group with N-lutyryl (CH3CH2CH2CO-) group renders the a-ketos[d[c 
bond resistant to neuraminidase [242,245]. These findings would 
suggest that neuraminidase possesses an active site pocket which the 
N-acetyl derivative substrate fits ideally and that an increase or 
decrease in the chain length of the acyl group tends to alter the critical 
distance and environment of the ketosidic bond from the catalytic groups 
in the active site of the enzyme. 
Modification of the carboxyl group in the sialic moiety of neuraminidase 
substrates has also been shown to result in their reduced susceptibility 
to neuraminidase hydrolysis. Thus, esterification of the carboxyl group 
of sialic acid in these substrates or its transfDrmation into primary 
alcohol or amido groups render the substrates resistant to neuraminidase 
and abolishes the inhibitory action of N-acetylneuraminic acid,, even when 
the steric requirements for neuraminidase substrates are retained (2421. 
Colominic acid , the 
homopolymer of sialic acids in a-2-8 ketosidic 
linkages, is usually a poor substrate for neuraminidase, releasing only 
20% of its total s(alic acid In one hour. W 1-ien colominic acid is treated 
withalkali and then digestedwith neuraminidase, all the sialic acid is 
released in I hour. It Is thought that some of the carboxyl groups of 
sialic acid are linked to the hydroxyl of the neighbouring monomer unit 
by an ester group to the C7 or C9 positions (Figure 3.2) [2461. 
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F. 3.2 Colominic acid showing the esterification of the carboxyl 
by C7 or C9 hydroxyl groups ( ----- ) 
Neuraminidases seem to require the carboxyl group of sialic acid in 
their substrates to be free and negatively charged for maximal activity 
[ 247] and evidence has been presented that the carboxyl group in the 
sialic acid moietymust bind to the enzyme in order to effect enzymatic 
cleavage of theketosidic bond [247,2481. 
As mentioned in Chapter 1, the aglycone in neuraminidase substrates 
maybe a monosaccharide, oligosaccharide, glycoprotein, glycolipid, 
aliphatic or aromatic alcohol. Only slight variations in the ability of 
neuraminidases to hydrolyse a-ketoside$ of N-acetylneuraminic acid 
having different neutral aglycones have been found. It is interesting that 
cx-ketosides containing neutral low molecular weight aglycones do not 
exhibit any affinity for the enzyme, an observation which reflects on the 
exolytic nature of neuraminidase. There are several cases in which the 
substitution of a bulky group in the aglycone results in diminished 
,g 
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activity of neuraminidase on such substrates, notably the resistance of 
monosialoganglioside to neuraminidase. After enzymatic removal of 
galactose or N-acetyl galactose, neuraminidase will release sialic acid 
from an otherwise res istant monos ialoganglios ide [2451. Also, in 
some glycoprotei &, o . lj 304j 'J7 of E tat C a:..:! cs : he re=or , -Ith 
g 
fragmentation of the macromolecules into small glycopeptides renders 
all sLalic acid susceptible to neuraminid. ase [245]. Introduction of a 
positively charged aminogroup or incorporation of a carboxyl group in 
the aglycone of an a-ketoside of N-acetylneuraminic acid results in a 
substrate possessing low affinity for the enzyme [ 241,245 ]. The 
aglycone may therefore be important to the action of neuraminidase in as 
far as its steric and electrostatic'shielding of the ketosidic bond or its 
interaction with the essential carboxyl group of sialic acid is concerned. 
Although the reactions catalysed by neuraminidase and the nature of 
the chemical structure required in the substrate in order to combine with 
the enzyme have been thoroughly investigated , 
little is known concerning 
the Identity of those amino acids Involved in substrate binding or 
catalysis. The question of the mechanism of neuraminidase has for the 
most part been approached, employing the philosophy of: 
"Give me a man's food and I will tell you about the man", 
L. M. Gerald, 1890 
which is more like defining the structure of the ideal key for an existing 
lock. This app. nnch suited the investigators who, although recognising 
the requirement for the key to possess a certain critical structure, did 
not study the mechanism by which the key turns in the lock, being more 
interested in the Ideal fit or its prevention in as far as they were pre- 
dominantly in search for a basis to design potent specific inhibitors of 
neuraminidase which would be protective against viruses containing this 
enzyme. 
3.2 Chemical modification of amino acid residues in proteins 
The recognition of the involvement of particular amino acid residues 
in the action of many enzymes has been failitated by the availability of 
group-specific modifying reagents. Glazer et al. [2491, Cohen [2501 
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and Stark [ 251 ] are a few of the many who have reviewed selected 
methods and analytical procedures employed in the modification of 
proteins., some of which methods have been adapted in the work 
reported in this thesis to assess the functional importance of various 
amino acid residues in the activity of neuraminidases. The reactivity 
of most proteins with these reagents arises from the reactivity of the 
side-chains of the basic amino acids (lysine, histidine and arginine ), 
the acidic amino acids (glutamic and aspartic acids), the sulphur 
containing amino acids (cysteine and methionine )and the activated 
aromatic amino acids (tyrosine and tryptophan ). The majority of 
protein modifications depend either on the nucleophilicity of the amino 
acid side-chains or on their ability to undergo oxidation. 
In typical modification studies the enzyme is treated under appropriate 
conditions with a large excess of amino acid-modifying reagent or with 
one that can be maintained at a constant level; at various times aliquots 
are assayed for enzyme activity and for amino acid content. In practice, 
the reactivity on the enzyme surface may not correlate with the 
reactivity of the free amino acid in solution. Sometimes the decrease in 
activity associated with the modification reaction cannot be interpreted In 
a simple manner and often the reactivity of the protein residues cannot be 
consistently predicted or controlled. These limitations of the modification 
approach to studying the active site of an enzyme relate to the complex 
environment of the amino acid groups as defined by the protein structure. 
The term "group-specific's as applied to the modifying reagents, represents 
a level of optimism not often achieved in practice. In fact, some authors 
[250]have preferred the term "group-selective" as a more accurate 
description of the reality that successful chemical modification of a 
single type of functional group in total exclusion of other types is the 
fortunate exception rather than the rule. Some of the amino acids to be 
modified may be involved in maintaining the structure and some in the 
recognition and binding of substrates, and even if the modification of one 
group is accompanied by the inactivation of the enzyme, steric effects, 
charge and conformational effects must be discounted before the group 
modified can be assigned a role in the action of the enzyme. 
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Although chemical modification of proteins involves such 
complicated inter-related effects, a great deal of information has 
been obtained from the careful application of this technique to active 
site studies. By employing many different reagents, the effect of 
modifying various groups can often be judged from the correlation 
between the rate of inactivation of the enzyme. Further information 
has been obtained from modification studies conducted in the presence 
or absence of the enzyme's substrate or inhibitor. Also, in cases 
where side reactions are known to occur there are often means of 
reversing the side reactions after the main modification reaction has 
been performed, or of preventing them altogether by employing certain 
specific conditions, especially of pH. It is also possible to assess the 
extent to which the dependence of activity on the conformational state 
of the protein is altered by the modification reaction by correlating its 
physical characteristics and its enzymatic activity. 
3.3 Active Site Studies on Neuram in idase 
The results obtained from the interaction of the chemically defined 
substrates with neuraminidases and the observed absence of metal ion 
participation (except in the case Vibrio cholerae neuraminidase) in 
this Interaction support the assumption that these enzymes possess 
catalytic sites of defined shape and size in which weak electrostatic 
forces and hydrogen -bonds are operative in the direct binding of the 
substrate. The kinetic investigations of the reactions of the pure 
enzymes with a range of substrates or inhibitors define the phenomena 
that the structure of these enzymes must explain. Structural 
Investigation of the active site provides a rational framework in which 
the amino acid residues important In catalysis or specificity can be 
described ; so far, chemical modification of the protein is the main 
approach ; )y which such active groups may be discovered, and their 
functional role established. 
It is only recently that the approach of studying the active site of 
an enzyme bychemical modification has been applied to neuraminidase. 
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Until the studies of Hoyle [252] and Bachmayer [2531, using group- 
specific reagents, insight into the nature of the active site of neura- 
minidase had been deduced from kinetic studies using various 
Inhibitors, especially sulphydryl reagents, . p-chloromercuri- 
benzoate (PCMB). 
The early work of Mohr [ 2541 showed that such sulphydryl 
reagents had no effect on Vibrio cholerae neuraminidase, while in 
related studies Ada [2551 reported inactivation of avian neuraminidase 
using PCMB and N-ethylmaleimide. 
C=O 
CH \ 
HgCI COOH 
CH 
C. O 
N 
p-chloromercuribenzoic acid CH 
(PC MB ) 
25 
N -ethylmale im ide 
Using these sulphydryl reagents, Tuppy and Palese [ 2561 excluded the 
participation of su lphydryl groups in the activity of pig kidney neura- 
minidase . The neuraminidases of rat-liver and kidney have also been 
shown to lack sulphydryl function [ 257 1. Kum imoto et al. [ 43 ] showed 
that neuraminidase from Cl. perfringens is inactivated by PCMB 
while the enzyme from S. griseus and Streptomyces purpeofuscus 
was not affected by treatment with this reagent. 
From chemical modification studies of intact influenz&virus, using 
Iodine and f luorod in itro benzene, Hoyle [ 2521 excluded sulphydryl groups, 
lysine, arginine and tryptophan, but implicated tyrosine and histidine 
as part of the active site of viral nueraminidase. However, the results 
of Bachmayer [253] following oxidation of purified viral and bacterial 
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neuraminidases with N-bromosuccinimide suggested an essential 
role of tryptophan In either the active side of the enzyme or In 
maintaining the Intact structure of the protein molecule required 
for activity of the enzyme. Further, nitration or acetylation of 
tyrosine residues and alkylation of cysteine residues affected 
neither the activity of influenza virus neuram In idase nor t'-ºat of 
the neuraminidase from Cl. perfringens. In a recent study of 
neuraminidase from an Arthrobacter species [2101, no 
inactivation was observed by reagents known to modify sulphydryl, 
lysyl (only slightly affected enzyme activity when modified), 
carboxyl, histidinyl and arginyl residues but treatment of the 
enzyme with N-bromosuccinimlderesulted In complete inactivation. 
It is yet to be established whether the apparent disagreement in 
the results of these studies reflect on the different mechanisms of 
action for neuraminidases of different origin or on the limitations 
of the techniques employed (for instance, side reactions, variations 
and Interferences In enzyme activity determinations, effectiveness 
of the modification reactions, etc. ) or on the differences in 
structures of these enzymes. The studies reported in this thesis 
were directed at comparing the effects of chemical modification of 
lysyl, arginyl, histidinyl,, carboxyl and tryptophan residues on the S. griseus 
activity of neuraminidases from/Cl. perfringens and influenza virus 
In the hope of Identifying the residues essential in catalysis. 
Similar studies were carried out on the neuraminidase from Vibrio 
cholerae neuraminidase by Groundwater [258) in this laboratory. 
3.4 Chemical Modification Reactions Employed 
The experimental procedures for the chemical modification of 
neuraminidases using the reactions described in this section are 
outlined in section 3.5. 
3.4.1 Modification of lysine residues 
The reaction of 2.4,, 6-trinitrobenzene sulphonic acid (TNBS) 
which under alkaline conditions appears to be predominantly 
restricted to a- and e-amino groups (Figure 3.3) was used to 
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modify lysine residues in neuraminidase. 
S03 OR NH NO 22 
R- NH2 + O2N 02N- 
02 pH>7 O 
+HSO 
2 
Figure 3.3 Reaction.. of TNBS with amino groups in proteins [259] 
3.4.2 Modification of histidine residues 
Photooxidation of proteins in solution by irradiation is conducted 
In the presence of oxygen and a photooxidising dye such as Rose Bengal. 
After absorption of light of suitable wavelength, the dye becomes 
energised, and is able to transfer energy directly to the photo- 
oxidisable residue oxidation. The mechanism of photochemical 
oxidation is complex and variable; it is thought to proceed viz: [ 2601 
D . --= D* 
D* +0 2 ý-- 
D02 
D02 +S ý-= D+ S02 
where D represents the dye, D* an excited electronic state of the dye 
and S the substrate (such as histidine). Although a variety of 
functional amino acids other than histidine, e. g. methionine, cysteine, 
tryptophan and tyrosine are subject to photooxidation, a degree of 
selectivity can be achieved by controlling the pH of the reaction [ 2611. 
Thus in acidic media methionine, cysteine, tryptophan and sulphydryl 
groups are oxidised while at neutral pH histidine is the most 
susceptible to oxidation. Diethyl pyrocarbonate has found some 
favour in its specific reaction with histidine residues in proteins 
(Figure 3.4) at slightly acid pH [2621. 
3.4.3 Modification of arginine residues 
A variety of procedures are available for the modification of 
arginine residues in proteins [ 249,250,251,263 1. The majority of 
arginine modification procedures have been conducted commonly 
employing 1,2-dicarbonyl compounds such as phenyl glyoxal or 
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Figure 3.4 Modification of histidine with diethyl pyrocarbonate 
butanedione and the recently described 1,3-dicarbonyl reagent 
(2,4-pentanedione) [ 264]. Although these procedures yield products 
which have not yet been fully characterised, they are performed 
under mild conditions and have been widely employed in enzyme 
studies. 
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(continued on next page) 
75. 
OCHO 
-( --000HO 
NH2 
+ 
)C-NHCH2)-- 
NH,. 
z it ýý \ 
II 
I 
ON 
NH 
O-` -- 
)r 
/1, 
C- NH--CH 23 
CH-NIL 
(b) C Cý- 
Fig. 3.5 Reaction of arginyl side-chains in proteins with (a) 2,4-pentane 
dione [264! j. (bl phenylgloxal [265) 
The reaction of 2,4-pentanedione with proteins effects the 
modification of both arginine and lysine residues. However, the 
modified lysine residues can be regenerated by dialysis or by 
treatment with hydroxylam ine (Figure 3.6). 
1) 1) yl 
CH -NHR 3CCH2CCH3 + RNH2 r-- CH3CCHCH3 
NH2OH 
'H 
OH 
CH C= CH CH + RNH 332 
Fig. 3.6 Regeneration of 2 4-pentanedione-modified lysines 
(enamines) by reaction with hydroxylamine 
The reaction of phenylglyoxal with proteins at pH 8 is mainly 
restricted to arginine residues, although 2-amino groups may also 
react. 
3.4.4 Modification of carboxyl groups 
The popular method of chemically modifying carboxyl groups in 
proteins involves the activation of the carboxyl groups by a water- 
soluble carbodiimide such as 1-ethyl-3 -(3 -dimethylaminopropyl) - 
carbodiimide and the subsequent reaction of the activated carboxyls 
with a nucleophile, e. g. glyc ine methyl ester [ 2661 at slightly acid pH. 
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Fig. 3.7 Reaction of a water-soluble carbodiimide (R'N=C=NR") 
with a protein carboxyl group (RCOOH) followed by rearrangement 
(i), hydrolysis (11) or attack by a nucleophile (HX) to form the 
mod if ied carboxyl group (RCOX )(iii ) 
Carbodiimides react with a number of functional groups at acid 
pH, the predominant of which are carboxyls, sulphydryls and 
tyrosines. The carbodiimide modified tyrosine residues may be 
regenerated by reaction with hydroxyl-amine, but no similar 
treatment has been reported to regenerate modified sulphydryl 
groups. Exposure of proteins to carbodiimide during modification 
studies leads to a covalent polymerisation of some protein 
molecules even in dilute acidic solutions [2671; however, nucleo- 
philic addition reactions are less susceptible to polymerisation 
effects. 
3.4.5 Modification of tryptophan residues 
Modification of tryptophan residues in proteins is often effected 
by oxidation with positive halogen reagents, particularly N-bromo- 
succinimide (NBS). The oxidation is conducted in an acidic medium 
with carefully controlled amounts of NBS when the indole moiety of 
tryptophan (A )is transformed to an oxyindole(B)accompanied by a 
reduction in absorption at 280 nm [2681. 
CH3 
H 
A 
H 
// 
IIH 
ro H 
B 
Side reactions encountered in the reaction of NBS with proteins may 
include the oxidation of tyrosine, methionine, cysteine, histidine or 
arginine residues as well as peptide cleavage. 
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3.5 Chemical Modification of Neuraminidases 
Experimental Procedure 
3.5.1 Preparation of neuraminidases 
S. griseus neuraminidase was prepared and purified as described 
in Chapter 2. Clostridium perfringens neuraminidase was obtained 
commercially and further purified by affinity chromatography 
according to the method of Brossmer et al. [204], using N-(4-nitro- 
phenyl -oxamic)ac id with Sepharose. 4B containing 1,6 -d iam inohexane 
as spacer group. Viral neuraminidase was isolated from influenza 
(A/Japan/305/57M rus. The virus was grown in the allantoic sac of 
11 -day-old chick embryos and was purified and concentrated from 
virus-infected allantoic fluid by low and high speed centrifugation 
essentially as described previously [271]. The virus preparation 
thus obtained was used toprepare neuraminidase by incubation with 
nagarse followed by sedimentation on linear sucrose gradients as 
described by Kendal and Eckert [211]. The amount of neuraminidase 
was determined based on its enzyme activity when assayed on fetuin 
as described below. A neuraminidase preparation (4.5 ml) of 
specific activity 285 U/ml was obtained from I litre of virus- 
infected allantoic fluid. 
3.5.2 Enzyme assays 
Unless otherwise stated, neuraminidase activity was determined 
using fetuin (5.0 mg/ml in assay buffer) as the substrate. The assay 
buffer was 0.05 M sodium acetate, pH 5.3, in the case of S. griseus 
neuraminidase, 0.05 M sodium acetate, pH 4.5, for Cl. perfringens 
neuraminidase and 0.1 M phosphate buffer, pH 6, in the case of 
7 8. 
Influenza virus neuraminidase. The enzyme solution (in amounts 
shown in the text) was added to the fetuin solution (0.5 ml) and the 
mixture (total volume 1.0 ml, made up with assay buffer) was incubated 
at 370 C for 60 minutes and the released s ialic acid was determined as 
described earlier. 
3.5.3 Lysine Modification 
TNi3S (trihydrate), obtained commercially, was recrystallised from 
hydrochloric acid according to the method described by Fields ; 2591 
before use. The incubation mixtures in the lys[ne modification experiments 
contained neuraminidase (amount depending on the source of the enzyme 
see legend, Figure 3.8) in 0.1 M sodium phosphate buffer, pH 7(2.0 ml) 
containing 5 mMTN13S. In the control incubation mixtures, TN13S was 
omitted. The reactions were carried out at room temperature for 6 
hours during which time aliquots (200 µl) were withdrawn at intervals 
and passed througha Sephadex G-25 column (1 x 10 cin ), equilibrated 
and eluted with the appropriate assay buffer. 'The effluent fractions 
contained mainly in the void volume were assayed for neuraminidase 
activity and for protein content. It was not possible to detect protein 
in significant amounts in effluent fractions of the viralenzyme. However, 
on account of its high molecular weight, its total exclusion from the 
Sephadex G -25 column was assumed and the volume of the effluent 
fraction containing the enzyme was measured and compared with 
sample loaded on the column (200 µl) to obtain the dilution of the 
original enzyme solution. 
From the results presented in Figure 3.8, it is apparent that the 
modification of lysine residues with TNI3S under the conditions 
described does not apprec [ably affect the activity of the three neura- 
minidases. Viralneuraminidase loses about 20%of its original 
(control activity), Cl. perfringens neuraminidase loses only 10%%, and 
S. griseus neuraminidase loses 5% of its original activity. 
3.5.4 Histidine modification 
Histidine residues in viral, S. griseus and Cl. perfringens neura- 
minidases were modified essentially according to the procedures 
described in similar studies by Dickenson and Dickinson [2691. 
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Fig. 3.8 Effect of lysine modification on the activity of 
neuraminidases. A. viral neuraminidase (30 units). 
B. S. griseus (0.3 mg). C. Cl. perfringens 
neuraminidase (0.4 mg). 
Photooxidation catalysed by Rose Bengal was performed at 250 C 
in the dark. The reaction mixtures each in a total volume of 3.0 ml 
(0.1 M sodium phosphate buffer, pH 7) P contained neuraminidase 
(S. griseus neuraminidase (0.3 mg), Cl. perfringens neuraminidase 
(0.4mg) and viral neuraminidase (30 units)) and Rose Bengal (1.0 µM ) 
in a cuvette held before a 500 W tungsten lamp. To counteract the 
heat dissipated by the lamp, ice-cold water was passed around the 
surfaces of the cuvette. Oxygen was bubbled gently through the 
contents of the cuvette. The oxidation was carried out for 60 minutes 
during which time 200 µ1aliquots were removed at intervals and 
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passed through a Sephadex G-25 column (1 x 10 cm), equilibrated 
and eluted with the appropriate assay buffer before 
determining their protein and neuraminidase content. 
The control reaction mixtures consisted of the enzyme and Rose 
Bengal in the quantities employed in the test samples, but were 
incubated at 250C In total darkness. A similar procedure (for the 
test and control reactions) was followed employing neuraminidase 
soluttons containing 0.05 M NANA or 0.2 mg/m1 sislyllactose. 
Modification of histidine residues in each of the three neuramint- 
dases was also carried out by incubating neuraminidase (S. griscus 
neuraminidase, 0.2 mg; Cl. perfringens neuraminidase, 0.4 mg; 
viral neuraminidase (30 units) with and without (1.5 mM) diethyl 
pyrocarbonate In 0.1 M sodium phosphate buffer, pH 7.0 (total 
volume, 1'. 0 ml) for 90 minutes at room temperature. During 
this period the reaction mixtures were gently stirred, and at 
intervals aligpots of the reaction mixture (100 µl) were removed 
and subjected to gel filtration on a Sephadex G-25 column (1 x 10 cm), 
previously equilibrated with the appropriate assay buffer 
before their protein and neuraminidase contents were determined. 
The results obtained in these studies are represented in Figure 3.9. 
3.5.5 Arginine modification 
(1) 2,4-pentaned! one 
Neuraminidase (amounts as in legend, Figure 3.10) in 0.5 M 
sodium phosphate buffer, pH 8.6 (2.0 ml) was mixed with 2,4 -pentane- 
dione (distilled before use) added to a total concentration of 50 mM. 
At various time intervals, an aliquot (200 wl) of the reaction mixture 
was withdrawn and subjected to gel filtration on a Sephadex G-25 
column (1 x 10 cm), using the appropriate assay buffer as the eluent. 
A fraction of the modified enzyme was assayed for activity and for 
protein and to the remainder hydroxylamine was added to a final 
concentration of 0.2 M. After 2 hours at 370 C, the solution was 
passed through a Sephadex G-25 column eluted with the assay buffer 
and the protein content and neuraminidase activity of the effluent were 
determined using the assay procedure described earlier. 
*NANA 
was used with S riseus and viral neuraminid ases while sialyl- 
lactose was used when treating Cl. perfringens neuraminidase. 
81. 
1 
90 - 
80 - 
70 tt, - 
U 60 - 
50 - 
E 40 
C) C 
o 30 A 
0 U 
6z 2n 
I 
y ýaý 
B 
05 10 15 20 25 30 35 40 45 50 55 60 0 10 20 30 40 50 60 70 SO 90 
Time of reaction (minutes) 
F. 3.9 Modification of histidine residues in neuraminidase of 
S. griseus (0), C1. perfringens (0) and Influenza 
virus (0) by photooxidation (A and by reaction with di ethy I 
pyrocarbonate (B) In the presence (solid lines) or abserce 
of 0.05 m%' N-acetylneuraminic acid (broken lines). 
In the case of Cl. perfringens neuraminidase, 0.2 mg/ml 
sialyllactose was used instead of 0.05 M IVANA (solid lines), 
without sialyllactose (broken lines). 
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F. 3.10 Effect of modifying arginyl residues with 2,4-pentanedione 
on the activity of neuraminidase from S. griseus (SG ), 
Cl. perfringens (CP) and influenza virus (N ); enzyme 
activity (- - -*) before, (-ý--ý-) after treatment 
with hydroxylamine. Amounts of enzymes modified: 
SG (0.3 mg), CP (0.4 mg) and N (4) units ). -;.., he 
control enzyme activity was obtained by assaying the 
enzyme solution kept under identical conditions but in 
the absence of the modifying rca: 2, cnt. 
(Li) Protection of Si_zriseu', anti virnIneur: iniin idn; es w' 1, N_ANa 
S. griseus neuraminidase (0.2 mg) was inculk; ted in 0.5 M 
sodium phosphate buffer, pH 8.6 (2 ml) with N-acetylneuraminic 
acid (30 mM) for 30 minutes before being treated with 2,4-pentadione 
(40 mM) and hydroxylamine as described above. Figure 3.11 shows 
the results obtained. A similar procedure was followed using viral 
neuraminidase (40 units). 
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Fig. 3.11 Protection of S. griseus (SG) and viral (IV) neuramIn idases 
against argin[ne modification by NANA. 
(--a-- --) unprotected, (- - +--. -) protected enzyme. 
(III) Phenylglyoxa l 
Modification reactions with phenylglyoxal were carried out on 
S. griseus and Cl. perfringens neuraminidases at room temperature 
(220 C) in 0.1 M N-ethylmorpholine acetate buffer, pH 8.0 [2651. 
The exact concentrations of the enzyme and reagent are given in the 
figure legends. The reactions were initiated by mixing the reagent 
and enzyme in a total volume of 1.0 ml . When the substrate 
(s ia lyllactose ) or inhibitor (NA NA) were used in protection 
Sc 
experiments, they were incubated with the enzyme solution before 
the modifying reagent was added. In these experiments, a 200 µl 
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aliquot of the reaction mixture was removed at various time 
intervals and the reaction was stopped by passage of this aliquot 
through a Sephadex G-25 (1 x 10 cm , equilibrated and eluted with 
the 
appropriate assay buffer at 4o C) to remove excess reagent. The 
effluent fractions containing protein were pooled and assayed for 
enzyme activity. The control incubation mixtures, which were 
similarly treated, contained the same amount of the enzyme as in 
the test, but lacked the modifying reagent. 
1 
wnl 
Ld 
cc 
U 
N 
C 
U 
O 
iý 
a. + 
C 
O 
U 
Vý 
Time of reaction (minutes) 
Fig. 3.12 Reaction of phenylglyoxal with S. griseus neuraminidase. 
The reaction was followed by the loss of enzyme activity. 
The modification reaction was carried out at 22 
0C in 0.1 M 
N-ethylmorpholine acetate buffer, pH 8.0 (1.0 ml) 
containing 0.5 mg neuraminidase. The residual enzyme 
activity determined after thegel filtration step was compared 
with that of the control (100% enzyme activity). The phenyl- 
glyoxal concentrations in different runs were: 0 1.0 mM 
(o-o-), 2.5 mM (0-) and 5.0 mM (. "ý. 
--x ,x -- modification of arginine residues in the presence of 
50mM NANA usingphenylglyoxilat 5 rnM concentration. 
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Fig. 3.13 Reaction of phenylglyoxalwith Cl. perfringens neuraminidase . 
Reaction conditions and measurement of modification as 
described for S. griseus neuraminidase. The enzyme 
concentration employed was 0.1 mg/ml and the phenyl- 
glyoxalconcentrations in the various runs were 0 (-. -"-), 
1.5 mM (-o-a-), 2.5 mM (c-o) and 5.0 mM 
the presence of 0.1 mg/misialyliactose. 
(iv) Incorporation of [7- 
14 Cl phenylglyoxal* in S4 riseus neuraminiciase 
The total number of arginine residues modifed was determined by 
incorporation of [14C] phenylglyoxal; the number of arginine residues 
Involved In the active site of S. griseus neuraminidase was determined 
by reacting the enzyme with unlabelled phenylglyoxal in the presence 
of NANA and after removal of excess reagent and NANA by gel 
*[ 14C 1 phenylglyoxal was agift of Dr. V. W. Armstrong, Max-Planck 
Institut, Gottingen. Its homogeneity was checked by comparing it 
with commercially available, unlabelled phen`lglyoxal of known 
purity by thin layer chromatography. The [1C] phenylglyoxal 
hydrate had a specific activity of 1350 cpm/nmole and was used 
without dilution with unlabelled phenylglyoxal. 
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filtration. the modified enzyme was further reacted with [ 
14C ] 
phenylglyoxal and from the label incorporated, the number of 
arginine residues protected by NANA were calculated, assuming 
a stoichiometry of 2 phenylglyoxal molecules per arginine residue 
modified [265]. 
The incorporation of [ 
14C ] phenylglyoxal into S. griseus neura- 
minidase was determined by incubating the enzyme (0.5 mg) at 370 C 
in a final volume of 1.0 ml with [ 
14C] 
phenylglyoxal (5 mM) in 0.1 M 
N-ethylmorpholine acetate buffer, pH 8.0, for 3 hours. After this 
period, the incubation mixture was mixed with 101/; trichloroacetic 
acid (2.0 ml). The resulting mixture was then filtered over a nitro- 
cellulose membrane filter (pore size 0.45 w, 25 mm diameter). The 
filter was washed with 20m1 10% trichloroacetic acid, dried under 
an infra-red lamp. The filter was placed in a scintillation vial 
containing 10ml scintillant (Triton, butyl B. P. D. ) and the radio- 
activity determined in a Packard Tri-carb liquid scintillation counter. 
S. griseus neuraminidase (0.5 mg) was also incubated at 370 C 
in a final volume of 1. Oml in 0.1 M N-ethylinorpholine acetate buffer, 
pH 8.0, containing NANA (30 mM) with unlabelled phenylglyoxal 
(2.0mM) for 2 hours at room temperature. The reaction mixture 
was then passed through a Sephadex G -25 column and eluted with 0.1 M 
N-ethylmorpholine acetate buffer, pH 8.0. The effluent fractions 
containing protein (as assayed according to the method of Lowry[ 2151 
were pooled and reacted with [ 
14C 
] phenylglyoxal (5.0 mM) for 2 
hours. The resulting reaction mixture was then mixed with 
10% trichloroacetic acid and further treated as described above to 
determine the radioactivity incorporated. Table 3.1 summarises the 
results obtained. 
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Table 3.1 Incorporation of [ 
14C] 
phenylglyoxal in riseus 
neuraminidase 
Reaction Amount enzyme Radioactivity No. of 
modified (kg) 1140 11, C* arginine 
incorporated residues 
(cpm) 
labelled/* 
" 32 000 m. wt. 
Neuram in idase 500 342180 8.1 
+ [14C] PG 
Neuraminidase 500 54849 1.3 
+NANA + PG (unlabelled) 
+[14C] PG 
PG - phenylglyoxal 
The number ofarginine residues labelled were calculated using a 
stoichiometry of 2 phenylglyoxal molecules per arginine residue 
modified [ 2651 and the specific activity of [ 
14C ] phenyiglyoxal of 
3 
1350x 10 cpm/µmole. A molecular weight of 32,000 for S. griseus 
was assumed. 
Thus for the total modification with [ 
14C ] phenylglyoxal, the 
342180 cpm obtained correspond to 
342180 
1350x103 
and to 
342180 
1350 x 103x2 
snn 
µmoles of phenyiglyoxal 
µmoles of arginine residues 
labelled in 32000 µmoles of neuraminidase. 
"I µmole of neuraminidase contains 
342180 x 32000 µmoles of labelled arginine residues 
1350 x 10 
3x2x 500 
= 8.1 labelled arginine residues. 
The value of 3-3.5 arginine residues obtained in an earlier 
report (see Appendix V, Kabayo, J. P. and Hutchinson D. W., FEBS Letts., 
78,223) for the same enzyme disagrees with the value of 8.1 
calculated above. The value of 3-3.5 was obtained after reacting 
3.7 mM phenylglyoxal with neuraminidase for 120 minutes while the 
value of 8.1 was obtained after a more thorough treatment of the 
enzyme with 5 mM phenylglyoxal for 3 hours. 
3.5.6 Carboxyl modification 
(a) The procedure described by Carraway and Koshland [ 266 ] was 
used to modify carboxyl groups in S. griseus , 
Cl. perfringens and 
influenza virus geuraminidases. In the modification reactions .a 
solution at pH 4.75 containing neuraminidase (amounts shown In 
Figure 3.14 legend) in 1.0 ml and glyc ine ethyl ester hydrochloride 
o (1.33 M) was kept at 25 C In a water-jacketed vessel attached to a 
pH-stat. Solid 1-ethyl -3-(3-dimethylaminopropyl )carbodiimide 
hydrochloride (EDC) was added to a final concentration of 0.5 M to 
Initiate the reaction. The pH of the reaction mixture was kept at pH 
4.75 by automatic titration with IN 1-IC1 and aliquots (200 ; 4) were 
removed periodically and subjected to gel filtration on Sephadex G-25 
(as described in the other types of modifications above, except that 
the columns were equilibrated and eluted with 0.05 M sodium phosphate 
buffer, pH 6, instead of acetate buffer [ 2661) before the specific 
enzyme activities were determined. In the control reactions, neura- 
minidase (in amounts employed in the tests) was treated similarly but 
in the absence of E DC. 
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Fig, 3.14 Modification of neuraminidases with EDC. S. c riseus (SC, 
0.5 mg), Cl. perfringens (CP, 1.0 mg) and influenza virus 
(IV, 50 units). 
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(b) Protection by NANA or sialyllactose 
To test the protection afforded by NANA in the modification of 
S. griseus neuraminidase with EDC as described above, the experiments 
were repeated in the presence of varying amounts of NANA (Figure 3.15). 
NANA was mixed with the enzyme and glycine ethyl ester before EDC 
was added. Similarly Cl. perfringens neuraminidase was modified 
in the presence bf varying amounts of sialylactose. 
100 
90 
80 
J.. 1 
70 
as co 60 
ca 
50 
ö 40 
0 
30 
20 
10 
0p10 
60 QO 1201 1 50 
Modification reaction time (niir. utes ) 
Fig. 3.15 Effect of EDC modification of S. griseus neuraminidase in 
the presence of: 10 mM (f-ý' 30 mM (. ") and 60 mM 
(+-s-) NANA. Control, in the absence of NANA, 
Modification of Cl. perfringens neuraminidase in the presence of 
0.2 ms/mlýv--w --- and absence (-O--ý--- ) of sialyllactose. (c) Incorporation of raradioactively labelled giycine into S. griseus 
neuraminidase 
(I) Synthesis of 
3H-glycine 
ethyl ester hydrochloride (3H-GEE ) 
The method described by Blomquist et al. [270] was used to prepare 
radioactively labelled 
3H-GEE 
by refluxing thionyl chloride ethanol 
90. 
and 
3H 
glycine (obtained commercially and diluted 10D-fold with 
unlabelled glycine). The product of the synthesis was recrystalliseI 
from absolute ethanol and compared with pure b lyc ine ethyl ester of 
commerical origin by melting point determination, elemental analysist 
NMR (D20) and paper chromatography. * The specific activity of the 
synthesised 
3H-GEE 
was determined. Table 3.2 summarises the 
analytical data of synthesised and commercially obtained glycine ethyl 
ester hydrochloride. 
Table 3.2 Analysis of 
3H-glycine 
ethyl ester hydrochloride 
Synthesised Commercial 
Melting point 
oC 
146.3 147. 
NUR (D20) signals Exchangeable Exchangeable 
protons and protons and 
ethyl moiety ethyl moiety 
Paper chromatography Major spot R f0.69 
One spot Rf0.72 
Minor spot Rf0.38 
Elemental analystst C 34.45 (33.93) 
H 7.15 (7.14) 
N 10.4 (9.89) 
Cl 25.6 (25.04) 
Ash 0.78 
Specific activity (cpm/nmole) 45 
(ii) Modification of S. griseus neuraminidase with 
3H-GEE 
The procedure described in section 3.5.6(a) was repeated using 
500 µg neuraminidase and 
3H-GEE instead of the unlabelled ester. 
The modification reaction was conducted in the absence of added NANA 
for 2 hours at the end of which the modified enzyme (after gel filtration 
as described above) was precipitated with 10`%% trichloroacetic acid (TCA). 
The precipitate, after filtration on a cellulose membrane filter, was 
washedwith 107 TCA , 
dried, and its radioactivity content was 
determined by standard liquid scintillation counting . 
tElemental 
analyses were performed by C. H. N. Analysis Ltd., South 
Wigston, Leicester. Values in brackets are calculated for C4H10C1N'02, 
Paper chromatography was performed on Whatman No. 1 paper 
employing ethanol/water (1: 1 by volume) and ninhydrin as developer. 
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Another sample of S. griseus neuraminidase (500 wg) was modified, 
in the presence of 50mM NANA, using unlabelled glycine ethyl ester 
for 60 minutes, and the reaction contents were subjected to gel 
filtration of SephadexG-25 as already described. The effluent protein 
fractions containing the modified enzyme were pooled and incubated 
with 
3H-GEE (1.3 M) andEDC for 60 minutes as before. The 
modified protein after filtration as described above, was precipitated 
with 10% TCA, washed, dried, and its radioactivity content was 
determined (Table 3.3). 
Table 3.3 Incorporat ion of 
3H 
-glyc ine in : neuramiaidase 
Reaction Amount enzym Incorporated 3Number of 
modified (g) I 
ýH-glycine (cpm) H-glycine 
incorporated per 
32000 M. Wt. * 
Total modification 500 46350 65.9 
with 
3H-GEE (NANA 
absent) 
Unlabelled modification 500 3485 4.9 
(NANA present) + 
3H-GEE 
3.5.7 Modification of tryptophan in S riseus and Cl. perfringens 
neuram in idases 
Modification of S. griseus and Cl. perfringens neuraminidases was 
carried out at room temperature using N-bromosuccinimide according 
to the method of Spande and Witkop [268). Each enzyme in 0.1 M 
sodium acetate buffer, pH 4.0 (2 ml) was reacted with N-bromo- 
succinimide (NBS) in various molar enzyme: NBS ratios (Figure 3.16) 
In the presence or absence of 50 mM NANA or 0.2 mg/inI s ia lyllactose 
for 10. minutes before determining its specific activity. 
The number of carboxyl residues modified correspond to the number 
of moles 
3H-glycine 
incorporated, assuming the specific activity 
of the 
3H-GEE 
used tobe 45 cpm/nmole, and a molecular weight of 
32P 000 for neuraminidase. 
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Fig. 3.16 The effect of NBS on S. griseus (A) and Cl. perfringens (B) 
neuraminidase activity in the presence or absence 
(--o---o--) of 50 mM NANA or 0.1 mg/ml sialyllactose. As 
before 
, 
NANAwas used to protect S. riseus neuramini&s e 
while sialyllactose was used to protect Cl. perfringens 
neuraminidase. 
In all these studies, the specific activities (enz,; me activity/mg 
protein) were measured in order to afford a more accurate 
comparison than if just the neuraminidase activity was to be 
measured. 
0 10 20 : 30 40 
Molar ratio (NBS) = neuraminidase 
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The quest for an understanding of the chemical basis of neuraminidase 
catalysts continues to represent a major segment of current biochemical 
research and some of the experimental avenues to this problem have 
been discussed above. In the present study the task has been the 
investigation of chemicalmodification approaches designed to gain 
understanding of the nature of the active site ofneuraminidases. The 
correlation of loss of activity with modification of particular amino acid 
residues in S. gr(seus, Cl. perfringens and influenza virus neuraminidases 
is summarised in Table 3.4 
Table 3.4 
Effect of chemical modification on neuraminidase activity " 
Modification procedure Amino acids modified ', 'control activity 
Predominant Siderenction after modification 
Without in presence of 
protection NANA or SL 
SG CP N SG CP IV 
TNBS 
Photooxidation 
Diethyl pyro - 
carbonate 
2,4-pentaned [one 
2,4-pentanedione + 
hydroxyla m ine 
Phenylglyoxal 
EDC 
NBS 
Lys Met, Cys 95 
His Met, Cys, 
Try, Tyr 85 
His 0 
Arg 
jI 
Lys 5 
Arg 
Arg 
Carboxyl 
groups 
(G1u, Asp) 
Try 
a-amino 
groups 
IPolymeris- 
Lýtion Cys, Tyr 
90 80 n. d. n. d. n. d. 
70 50 85 70 60 
80 70 n. d. n. d. n. d. 
15 20 n. d. n. d. n. d. 
0 25 35; 85 80 
5 
25 
Tyr, Met, 
Cys, His, 
Arg, 
Peptide 
cleavage 
I0 
SL - sialyllactose. 
n. d. - not determined. 
SG - S. griseus neuramin idase . CP - Cl. perfringensneuraminidase . IV - Influenza virus neuraminidase. 
so 
15 n. dL 85 90 n, d. 
15 101 60 75 n. d. 
5 n, d f 65 75 n, d. 
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The reaction of each of the three neuraminidases with the various 
modifying reagents achieved the inactivation of the enzyme to different 
extents. The most pronounced inactivation effect was obtained when 
the reagents known to modify arginine, tryptophan and carboxylic 
amino acids were reacted with the enzyme. In these modifications the 
resulting enzyme inactivation followed pseudo-first order kinetics and, 
In the case of arginine and tryptophan, modification was retarded by NANA 
or sialyllactose. These results are consistent with the likelihood that 
these amino acid residues are In or near the active site region of the 
enzyme and this proposition is further supported by the demonstration 
that the residues were protected by substrate or competitive inhibitor. 
The modification of carboxyl groups was not completely protected by 
NANA in the case of S. griseus neuraminidase or by sialyllactose in 
the case of Cl. perfringens neuraminidase , and 
therefore these amino 
acid groups probably participate much more in the catalytic than the 
substrate-binding events of the enzyme function. It is also possible 
that these groups may not be sufficiently protected on account of their 
weak binding with the inhibitor or with the substrate. Alternatively, they 
may be situated at positions near the active centre but where they do not 
maximally interact with the substrate or inhibitor. The modification of 
4.9 carboxyl groups/molS, rig seus neuraminidase (Table 3.3, page 91) 
by EDC and glycine ethyl esterwith simultaneous loss of 757, of enzyme 
activity is fairly specific since there are 65.9 free carboxyl groups in 
this enzyme as measured by the amount of 
3H-glycine 
ethyl ester. The 
value of 65.9 is close to that of 61.9 obtained from the sum of glutamic 
and aspartic acid residues as determined by amino acid analysis (Table 
2.7, page 47). 
In S. griseus neuraminidase, the incorporation of 
14C-phenylglyoxal 
showed that 1.3 out of 8.1 arginine residues per mol of the enzyme are 
protected by NANA and are possibly involved in the active site of the 
enzyme. 
The observed reduced activities of the enzymes after reaction with 
TNBS or diethylpyrocarbonate or after photooxidation may be due to the 
operating side effects of these treatments. Viral neuraminidase, although 
9;. 
shown to lack free sulphydrylgroups [2111 and although its activity is 
known not to Involve sulphydryl groups [ 252 1, has a tetra meric 
structure now known to depend on disulphide bonds [ 2121. Therefore 
treatments such as photooxidation known to affect cysteine, even if 
slowly, under the conditions employed, would be expected to show an 
effect on the enzyme activity. Although the effect of the modification 
procedures employed on the structure of neuraminidase was not 
investigated In these studies, It was possible to distinguish such effects 
from those occurring at or near the active site of the enzymes by 
performing the modifications in the presence or absence of a competitive 
inhibitor or substrate of the enzyme. Neuraminidase from Vibrio 
cholerae has been shown to lack sulphydryl and primary aminogroups 
essentialfor catalytic activity [254,2721 although Groundwater in this 
laboratory [ 258] usedTNBS to modify the V. cholerae enzyme and 
observed a. 78%inactivation of its activity as a result of this treatment. 
However, this Inactivation was not retarded by NANA. Parker et al. 
[ 1881 were able to immobilise Cl. perfringens neuramin idase on 
cyanogen bromide -activated Sepharose and other supports, presumably 
through terminal am ino groups . 
and although these amino groups were 
possibly not part of the active site, the treatment provides circum- 
stantial evidence that the amino groups of this enzyme are not crucial 
for its activity. The results obtained in this study for this enzyme using 
TNBS are consistent with such suggestions. The slight reduction (10 ) 
in the activity after the TINS treatment of this enzyme may have been due 
to the side reactions of the reagent that affect suiphydryl groups which 
are probably crucialfor the activity of the Cl. perfringens enzyme [43]. 
In the case of S. griseusneuraminidase, neitherhi-, tidine nor lysine 
residues seem essentialfor the activity . This is in keeping with the 
results from the kinetic investigation of the effect of added metal ions 
on the enzyme (seepage 54, Table 2.8 ). It is known that at increasing 
metal ion concentrations, primary amino groups, imidazole and carboxyl 
groups appear to co-ordinate with the metals [ 273 ]. Since the added 
metal ions did not affect the enzyme activity appreciably, these groups 
96. 
were either not fully co-ordinated with the metal ions (especially the 
carboxyls whichare quite numerous in this enzyme, see page 62 and 
Table 2.7) or altogether unnecessary for the activity of the enzyme. 
However, the evidence from the carboxyl modification of S. griseus 
neuraminidase would imply that the carboxyl groups are necessary 
for full enzymic activity. 
Neuraminidases from different sources are immunologically 
distinguishable and are therefore an isodynam is group of enzymes which 
catalyse the same reaction but differ in a number of fundamental 
properties such as pll, ion require nt. substratc specificities and inhibition. 
Since these enzymes catalyse the same reaction, it is reasonable to 
propose that essentially similar catalytic events take place when the 
enzymes from different sources act. The activities of neuraminidases 
are necessarily difficult to compare because as well as possessing 
different structural properties . 
their substrates in themselves vary in 
structure depending on whether they are 2- 3P 2 -" 6 or 2 -y 8 ci-ketos ides 
of sialic acid (seepage 28, Fig. 2.1 ). Often the substrates used to assay 
and to characterise different neuraminidases contain a mixture of these 
ketosides whose absolute geometries must affect the interaction of 
neuraminidases possessing different structural environments to varying 
degrees. Dxzeniek [ 2741 carried out inhibitory experiments which 
demonstrated that the rate limiting factor of the enzymatic process is not 
the enzyme substrate-binding but the hydrolysis of the substrate. All 
sialic-acid-containing substrates could potentially bind to neuraminidase 
but differences can be expected with respect to the ease at which the 
neuraminidase can elute from different substrates by splitting off sialic 
acid. The elution from different substrates of different neuraminidases 
may thus depend on the intimate interaction of the substrate with the 
enzyme. This will in turn be influenced by various factors relating to 
the structure of the active site of the enzyme, for example the molecular 
environment of the active site, the size of the active site, etc. The 
results of the modification studies in the present study indicate that the 
three types of neuramin idases have common amino acid residues 
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essential for their activity, namely arginine, tryptophan and carboxylic 
amino acids. The results of previous modification studies on neura- 
minidases by other workers were mentioned above (see pages 70-72) and 
although a few are contradictory to the result of the present study, it is 
interesting to consider the aspects in which the participation of arginine, 
tryptophan andcarboxyls would fit in with the activity of neuraminidase 
or related enzymes. 
Neuraminidase catalyses the hydrolytic cleavage of the a-ketosidic 
linkage thatjoins sialic acid to glycoproteins, glycolipids and oligo- 
saccharides. The presence of a free terminal o-carboxyl group of 
the substrate is a strict specificity requirement of this enzyme [ 247,2451 
and because of such specificity for the anionic form of the sialyl substrate, 
It is likely that a positively charged recognition site at the active centre 
of the enzyme would be required for the binding of the substrate. The 
involvement of a meta 1 [on for this purpose has not been definitively 
Implicated [tithe catalytic or binding function of neuraminidase. A 
positively charged aminoacid residue such as lysine, histidine or 
arginine, whlchexist in their ionised form over the usual pH range of 
enzyme stability could be considered as the most likely alternative. 
The experiments reported above have excluded participation of lysine 
or histidineresidues in binding functions. In contrast the results 
available from these experiments indicate that arginine is critical for 
enzyme activity. At least 1000 of the more than 1500 enzymes now 
known act on negatively charged substrates or require anionic cofactors, 
and a number of reports have suggested that arginyl residues often serve 
as the complementary, positively charged recognition sites. 
Tryptophan, which was also found to be essential for neuraminidase 
activity in the present study, has been shown to take active part in carbo- 
hydrate-protein interactions in some carbohydrate-binding proteins, for 
instance lysozyme [2751, some lectins [276 J and a-mannos idase from 
Phaseolus vulgaris [277], to mention a few. Further, theneuraminidases 
from an Arthrobacter species [ 210], Cl. perfringens, and influenza virus 
[253] were all shown to possess an essential tryptophan residue either in 
the active site or in maintaining the intact structure of the protein 
molecule necessary for the activity of neuraminidase. 
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The finding In the present study that carboxylgroups appear to be 
involved In the catalytic activity ofneuraminidase is analogous to the 
findings for some other glycosidases such as sucrose -isoma ltase [278], 
lysozyme [ 275] and Aspergillus wentii $-glucosidase [279]. The 
participation of a dissociable group such as a carboxyl group, active in 
enzyme action In. the protonated form, with a pH dependence similar to 
that of the carbodlimide reaction may be suggested by the optimal pH 
(about 5.0) of several neuraminidases, and is the most likely candidate 
as a proton-donating amino acid group . 
In the case of lysozyme [27S] 
it has been suggested that the most reasonable explanation of the 
catalytic activity is that twocarlxoxyl groups (Asp 52 and Clu 33) which are 
close to the Inhibitor-binding site function act as base and ac id to effect 
hydrolysis of susceptible glycosidic bonds. In the case of neuraminidase 
only the report of Homquist [ 2421 dealing with the effect of carboxyl 
modification of Vibrio cholerae neuraminidase with ethyl diazoacetate has 
appeared. However, the fact that a-ketos ides of s is lic acid bearing an 
anionic group In the polyhydroxy side chain are neither substrates nor 
inhibitors of the enzyme [240] is suggestive of the possibility that the 
active site of neuraminidase may be associated with a negatively charged 
residue such as a carboxylgroup. 
Speculations on the mechanism of neuraminidase action 
The mechanism of nonenzymatic hydrolysis of glycosidic and ketosidic 
bonds Is now established [280] as a unimolecular reaction involving fission 
of the carbonyl-carbon-oxygen bondwit_hac clic car'_or_i, -? :: oxccazýrýi 
ion. 'ms an Mate eel)( cdiatt:. Corde; and 
BýILLI 2äV 
as the possible mechanisms for the cleavage of carbonyl-carbon-oxygen 
bonds: 
(a) Protonation of the oxygen atom followed by the rate determining 
formation of an oxocarbonium ion (specific acid catalysis). 
(b) Concerted proton transfer and cleavage of the carbon y l-carbon -oxygen 
bond with formation of an oxocarbonium ion (general acid catalysis ). 
(c) Attack by nucleophiles. 
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It is thought that a similar mechanistic pathway involving an inter- 
mediate oxocarbonlum ion, possibly formed following protonation of 
a glycosidic oxygen atom by an acid group, e. g. protonated carboxylic 
side chain, could function in the enzyme -cata lysed hydrolysis of glyco- 
sidic bonds. Indeed, such an intermediate carbonium ion is known to be 
formed in the case of lysozyme [275] and V ibrio cholerae neuraminidase 
[281 ]. The action of neuraminidase has been formulated [2811: 
HO+ HO 
E+S - E-S -3- Eý-P1+P2 
2, E-P1-OH+H30++P2 = E+P1-OH + 
H3O++P2 
In this sequencea cyclic oxocarbonium ion of N-acetylneuraminic acid 
(Fig. 3.17A) Is assumed to react-with water to produce the 6-anomer 
directly or by anomerisation of an initially formed a-anomer. 
HO , 'IH ,N 
HOH2C C0 CH 
ýH 
Hý \', OH 0_C1 OH 
2µ 
; of 
HG 0 ACNH ACNfi C- oI; OH 
OH 
A. B. 
Figure 3.17 A. Structure of the cyclic oxocarbonium ion of N-acetyl- 
neuraminic acid. 
B. 2-deoxy-2,3-dehydro-N-acetylneuraminic acid 
In the reaction sequence depicted above, PI represents the cyclic oxo- 
carbonium ion, P1 -OHS the free N-acetylneuraminic acid, P2 the 
released aglycone, E the enzyme and S the substrate. Flashner et al. 
[2821 have found that 2-deoxy-2,3-dehydro-N-acetylneuraminic acid 
(Figure 3.17B) and its methyl ester are transition state analogues for 
neuraminidase and their structural resemblances to the oxocarbonium 
ion support the hypothesis that an oxocarbon ium -like Loa is generated 
during substrate catalysis of neuraminidase. 
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Since the aglycone moiety of natural or synthetic substrates for neura- 
minidase pose little steric hindrance to the enzyme, it is most probable 
that the enzyme approaches its substrate from the sialic acid moiety, 
and assuming the neuraminldase possesses a cleft or pocket into which 
the sialic acid moiety fits (Figure 3.18), it is reasonable to suppose that 
a hydrophobic amino acid residue such as tryptophan would interact with the 
polyhydroxy c ha In. 
CHO-r`` 
Cý 
HUH 
CýUý 
CH 
3 
Cý CN QR 
NEURAMINIDASE 
Figure 3.18 Possible mechanism of substrate binding by neuraminidase 
The free carboxyl of the substrate, which is obligatory for the action 
of neuraminidase, may function by binding to a positively charged residue 
such as arginine and may in the process distort the sialic acid molecule 
from its normal 
2C5 
conformation into that approaching a half-chain' 
conformation [ 282]. Further, the guanidino groups of arginine may 
have a function beyond that of merely binding the substrate such as 
accelerating the hydrolysis reaction by neutralising the negative charge on 
the substrate carbonyl-carbon-oxygen and partially polarising it, an effect 
which would tend to electrostatically stabilise the cyclic oxocarbonium ion 
formed by the cleavage of the glycosidic bond. 
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Involvement of one or more carboxyl groups in the catalytic mechanism 
of neuraminidase is a possible working hypothesis by analogy with the 
well-known example of lysozyme [ 2751 in which a carboxyl group 
promotes the formation of an intermediate carbonium ion by donating a 
proton to the glycosidic oxygen. Thus, in the case of neuraminidase, the 
following Figure (3.19) may be the mechanism by which ar-ketosides of 
sialic acid are cleaved, 
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Fig. 3.19 Possible hydrolytic mechanism ofneuraminidase 
The release of the free sialic acid after hydrolysis would probably be 
facilitated by an electrostatic repulsion between the formed positively 
charged oxocarbonium ion and the positively charged guanidino group 
of arginine. In addition to this, the release of the free sialic acid 
(breakdown of E.. F1 - OH) is effected by the rapid anomerisation of sialic 
acid to its ß -anomer or by the direct formation of the latter [ 242,281 1. 
3.7 Conclusion 
The importance of neuraminidase has already been discussed above. The 
results from the present studies on neuram in idases can at the moment afford 
only a hypothetical explanation of the mechanism of neuraminidase action. 
More light can be expected from other approaches such as X-ray studies, 
transition -state affinity label alaalysis, peptide mapping techniques, etc. 
With the improved methods now available for the purification of neuraminidase 
and the increasing task force of enzymologists and protein chemists now 
interested in the enzyme, it may not be long before the knowledge on the 
mechanism of neuraminidase is complete. 
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APPENDIX I 
Practical application of purified S" griseus neuraminidase 
Treatment of interferon with neu ram inidase 
Most Interferons are probablyglycoprote ins. While investigating 
the functional and structural composition of the carbohydrate moiety, 
Dorner et al. [2831 treated rabbit interferon with neuraminidase as 
a result of which they observed considerable decrease in its charge 
heterogeneity on isoleclectric focussing. However, the neuraminidase 
utilised in these studies had been purified by an affinity chromatographic 
method [ 174] which has now been shown to be non-specific [ 206,207] 
Further, the separation procedures employed in isolelectric focussing 
were assumed to achieve total dissociation of the protein complexes 
Involved in the study. 
In the studies reported below, the extensively purified neuraminidase 
from S. griseus neuraminidase was used to treat human fibroblast 
leucocyte and lymphoblastoid interferons, after which the isoelectric 
focussing method of O'Farrell [284], in which full dissociation of 
protein complexes is known to occur, was used to analyse the enzyme - 
treated Interferons. 
As well as testing the validity of studies by Dorner et al. ( 283 1, the 
present studies also aimed at investigating any sialylation differences in 
the three Interferons tested. 
*Leucocyte interferon (2500 units ), lymphoblasto; d interferon 
(2500 units) and fibroblast interferon (1000 units) were each incubated 
withpurified S. griseus neuraminidase (50 µg) and 0.05 'Ä sodium 
acetate buffer, pH 5.3 (250 µl), at 37 C for 3 hours. The corresponding 
controls were similarly incubated in the absence of neuraminidase. After 
the incubations, the samples were analysed by isoelectric focussing 
essentially as described by O'Farrell [ 284 ) except that 2-mercapto- 
ethanol was omitted from all buffers and 0.25!; SDS was included in the 
sample buffer. After isoelectric focussing, the gels were either 
The three Interferons were provided and assayed by Dr. J. M. Morser. 
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stained for protein with Coomassie blue or sliced into 
0.25 cm segments, each of which was placed in phosphate buffered 
saline (PBS) and dialysed exhaustively against PBS before its interferon 
content was determined. The pH gradient in the isoelectric focussing 
gels was determined and the Isoelectric points of the three Interferons 
were estimated (Figure A. 1 ). 
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Figure A. I Isoelectric focussing of human Interferons; (a) leucocyte 
interferon, (b) leucocyte interferon treated with neuraminidase, 
(c) lymphoblastoid Interferon, (d) lymphoblastoid interferon treated 
with neuramin idase, (e) fibroblast interferon, (f) fibroblast interferon 
treated with neuraminIdase. .... ". " pH. 
5 
Fetu in (150 µg was incubated with neuram in Ida se (50 gig) at 37 C 
for 0,10,30,40 and 60 minutes . after which incubation the samples 
were analysed by isoelectric focusing as described for interferon above, 
and stained forproteto (Figure A. 2). 
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Figure A. 2 Isoelectric focussing of neuraminidase -treated fetuln. 
F0-F40 fetuln treated with neuraminidase for the times (minutes) 
indicated by subscript. 
Fetuin treated with neuraminidase for 60 minutes or longer (not 
shown in Figure A. 2) was identical to F40 on isoelectric focu4ing. 
The amount of sialic acid produced in each incubation was determined 
and compared with the corresponding electrophoretic migration. The 
fetuin used in these studies (prepared by the method of Spiro [2141) 
appeared as multiple bands on isoelectric focussing in contrast to that 
prepared by the same method and reported to be homogeneous [2141. 
Therefore, to measure the migration of the bands, the midpoint of the 
band area was chosen and its distance from the origin was measured. 
From Figure A. 1 it would seem that only human fibroblast interferon 
was significantly altered by treatment with neuraminidase. Prior to the 
enzyme treatment, three peaks of fibroblast interferon activity could be 
detected with isoelectric points 5.2,5.8 and 6.3. After treatment 
with neuramin idase, only one peak of interferon activity with an iso- 
electric point of 6.3 was detected. In the case of lymphoblastoid and 
leucocyte interferons, no change in their isoelectric points (5.5 and 
5.3 respectively) following their treatment with neuraminidase could 
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Figure A. 3 Relationship between the sialicacid content of fetuin 
and its corresponding migration in isoelectric focusing. 
be detected. In a related study, Mogenson et al. [ 284 j also observed 
that the isoelectrlc focussing pattern of human leucocyte interferon 
was not changed appreciably by treatment of the Interferon with 
neuramin[dase. 
The isoelectric focussing pattern of fetuin (Figure A. 2) was changed 
appreciably by treatment of this glycoprotein with neuraminidase. The 
three forms of fibroblast interferon, separable on the basis of their 
intrinsic charge would reflect on their sialic acid content being more 
acidic the more sialic acid they contain. The form of fibroblast 
interferon with an isoelectric point of pH 6.3, both leucocyte and 
lymphoblastoid Interferons as well as fetuin treated with the enzyme 
for 40 minutes or longer, probably lack neuraminidase-susceptible 
sialic acid residues. 
It is interesting that two species of fetuin differing by as little as 
0.1 µg sialic ac id content may be'visualised'as two bands at least 0.5 
cm apart (Figure A. 3 ). The isoelectric point of untreated fetuin was 
found to be about 3.5; after treatment with neuraminidase the iso- 
1U5. 
electric point Was raised to pH 5.4. This analytical technique has 
great potential in assessing the content of sialic acid In substances 
such as interferon which are normally available in amounts too low 
to afford quantitative estimation of sialic acid. The technique may 
also be applied to indirectly assess neuraminidase amounts since 
there is a direct relationship (Figure A. 3 ) between the sialic acid 
content and isoelectric point. 
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APPENDIX II 
A. 2Attempt to Design a Radioimmuno Assay for Sialic Acid 
A. 2.1 Introduction 
Most of the problems associated with the determination of free 
sialic acid (and neuram inidase activity), some of which have been 
mentioned in Chapter 2, relate to the limitations in the specificity 
and/or sensitivity of the techniques employed. The rapidly growing 
list of new methods used to quantitate sialic acid is suggestive of the 
dissatisfaction expressed by various investigators at the currently 
available techniques. 
The techniques of radioimmuno assay, first developed for the 
measurement of hormones, has expanded over the last two decades to 
include the detection of many other biological substances. The reasons 
for such wide application of this technique derive from its high 
sensitivity, specificity and precision compared to other analytical 
methods. In atypical radioimmunoassay ' 
the antibodies (Ab) to the 
biological substance of interest (antigen, Ag) are prepared and used 
to determine the concentration of the antigen, following observations 
in which the radiolabelled antigen molecules compete with the non- 
labelled antigen molecules for a limited number of binding sites on 
the antibodies. Figure B. 1 summarises the reactions, Involved in 
radioimmunoassays [286]. 
Ag* + Ab - 
free labelled antigen specific antibody 
+ Ag 
1i Ag-Ab 
unlabelled antigen- 
antibody complex 
Ag* -Ab 
labelled antigen- 
antibody complex 
Figure B. I Summary of the principles of a radioimmunoassay 
The mixture of Abi Agand Ag*, in which there is a fixed amount of 
Abbut a relative excess of Ag, is incubated to allow establishment of 
an equlibrium before the antigen -antibody complexes (Ag-Ab and Ag* -Ab) 
10i.. 
are separated from free unbound Ag* and Ag. The radioactivity of 
complexed or free Ag* or both is measured. When increasing amounts 
of unlabelled antigen are added to the assay, the limited binding sites 
of the antibody can bind less of the radiolabelled antigen. A 
diminished binding of labelled antigen offers evidence for the presence 
unlabelled antigen. The concentration of the unlabelled sample 
antigen can then be obtained by comparing the observed inhibition of 
labelled antigen bindingwith that obtained by standard solutions 
containing known amounts of antigen. 
Any compound can be measured by the radiolmmunoassay technique 
provided that: 
(a) it can be made Immunogenic; 
(b) it is available in pure form ; 
(c) It can be radioactively labelled ; 
(d) there Is a technique available to separate the antibody, complexed 
from the free compound. 
Both unlabelled and labelled N-acetyl neuraminic acid are available 
commercially, but neither antibodies to sialic acid nor attempts to 
design a radIoimmuno assay for Its determination have been reported. 
A number of reports (especially on tumour immunology) have shown 
that sialic acids may play a peculiar negative role in masking 
antigenic determinants expressed by tumour cell surfaces [287] or 
normal cells [288] or soluble sialoglycoproteins [ 53 ]. Although this 
would relect on the poor Immunogenicity of sialic acid, there are several 
reports in which sialic acid has been shown to be an immunodeterminant 
sugar. 
It has long been known that blood group specificities are determined 
by carbohydrate moieties of erythrocyte glycoproteins and glycolipids. 
Sialic acids in particular, are responsible for the antigenic specificities 
associated with the MN [ 289 ], F[ 290], Pr1 and Pr2 [ 291 ] 
systems. While investigating the in vitro relationships of sialic acids 
to the A, B, M, N, C, D and E agglutinogens of the human erythrocytes 
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by means of the Landsteiner haptens inhibition test, Rule [ 2921 
obtained results whic h suggested that sialic acid is a major 
constituent of the D(Rho) and MN agglutinogens and showed that 
bothcolominic acid(from E. coli K 235 L+ Cl) and N-acetylneuraminic 
acid bind to anti-D. In other studies, Lisowka and Roelcke [ 293, 
showed that after periodate oxidation of red cell glycoproteins resulting 
In sialic acids with shortened polyhydroxy side chain, the Pr1 and MN 
antigens were inactivated. Prat andComoglio [ 294 ] obtained 
ajitisera solubilised membrane antigens from a mouse plasma cell 
tumour and by radio immunoprecipitation techniques showed that the 
removal of sialic acid residues, withVibrio cholerae neuraminidase, 
from the antigens significantly lowered theprecipitation curves; in 
a competitive radioimmunoassay the desialysed antigens only 
partially inhibited the binding of radiolabelled antibodies to native 
antigens. Serological investigation of a mucopolysaccharide, 
obtained from the S-form of Salmonella ngozi, built up predominantly 
of sialic acid and hexosamines yielded results, the interpretation 
of which identified N-acetylneuraminic acid as the immunodeterminant 
sugar [ 295 ], A polysaccharide isolated from Neisseria meningitis 
group C and identified as a homopolymer of sialic acid has been shown 
to be immunogenic in rabbits and sheep [ 296 1 and in a recent 
investigation of the type III polysaccharide isolated from group B 
Streptococcus, sialic acid was identified as the major c: iemical 
constituent of the antigen, accounting for more than 25 of its carbo- 
hydrate [ 297 ]. Egan et al. [ 298 ] isolated a polysaccharide antigen 
from E. colt strain Bos-12 which was characterised as a polymer of 
sialic acids in 2'--8linkages similar to colominic acid. Sialic acid 
has also recently been shown to be involved in the antigenic 
determinant of a glycopeptide from fetuin [ 299 ], Figure B. 2, in 
contrast to an earlier report [ 300 ] in whIch fetuin was judged to be 
devoid of any carbohydrate antigenic determinants. 
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Figure B. 2 Structure of possible carbohydrate immunodeterminant 
moiety In fetuin [ 299 ]. NANA is N-acetylneuraminic 
acid. 
In thepresept study, colominic acid and fetuin were used as antigens 
aga[nstwhich antibodies were raised in rabbits; attempts were made to 
isolate antibodlesspecific tosialic acid with which to design a 
competition assay for the determination of sialic acid concentrations. 
A. 2.2 Experimental Procedure 
New Zealand white rabbits were immunised at intervals of two 
weeks, each time with fetuin (20 mg/ml in PBS) or colominic acid 
(15 mg/ml in PBS) emulsified 1: 1 in Freund's complete adjuvant and 
injected subcutaneously in the neck. Control bleeds were taken 
from the animals before immunisation. Test bleeds were taken from 
the animals six days after the second and subsequent injections of 
fetuin or colominic acid and the immunisation programme was 
continued until there was no further increase in the antibody titre. 
The blood collected separately from the rabbits injected with fetuin 
and from those injected with colominie acid was allowed to clot for 
2 hours at room temperature and the sera were decanted from the 
clots and centrifuged at 4o C at 1500 x gfor 30 minutes. The serum 
thus -collected was subjected to various immunological tests [ 301 ] 
for antibody activity. 
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(a) Interfacial ring test 
Serum (0.1 ml) from fetuin-orcolominic acid-injected rabbits 
was placed in a small Durham tube and 0.1 ml of fetuin (15 mg/ml 
in PBS) or colominic acid (15 mg/ml in PBS) respectively was 
carefully added. After the second injection, a precipitation ring 
was observed in the tubes to which antiserum to fetuin and fetuin 
were present; po similar ring was observed in the case of colominic 
acid even after the seventh injection of colominic acid into the 
rabbits. Pure sialic acid also did not form a precipitation ring when 
added to either antifetuin or anticolominic acid sera. 
(b) Immunodiffus ion 
The double diffusion technique was conducted on microscope 
slides coated with 2%, agar (Noble, special for electrophoresis) gels 
in 0.08 M barbitone buffer, pH 8.2. Precipitation lines were 
visible in the case of fetuin antiserum (Figure 13.3) but not collected 
from colominic acid-injected rabbits. The gels were dried and 
stained with Coomassie blue. 
Figure B. 3 Double immunodiffusion of rabbit antifetuin antiserum. 
A. diluted 1: 1 with PBS .B fetuin (5 mg/ml). C. desialysed 
fetuin*. D. N-acetylneuraminic acid (5 mg/ml). 
E. colominic acid (5 mg/ml). 
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* Desialysed fetuin was prepared by incubating fetuin (I ml, 5 mg/ml 
in 0.05 M sodium acetate buffer, pH 5) with neuraminidase (0.5 ml, 
0.5 mg/ml in 0.05 M sodium acetate buffer, pH 5) from Clostridium 
perfringens at 37 Cfor 6 hours. The incubation mixture was then 
exhaustively dialysed against PBS before being used in the immuno- 
diffusion test. Further treatment of this desialysed fetuin with 
neuraminidase did not release any sialic acid as measured by the 
thiobarbituric acid test [196]. 
(c) Farr assay 
The Farr assay Involves the reaction of a radiolabelled antigen with 
antibody followed by precipitation of the resulting antibody -antigen 
complex with saturated ammonium sulphate. Since ammonium sulphate 
added to serum Fo 50% saturation precipitates most immunoglobins, 
leavingother serumproteins insolution, the radioactivity associated 
with the precipitate formed from a mixture of antibody and antigen will 
be due to the labelled antigen complexed with antibody. 
It became interestingto find out if there were antibodies to sialic 
acid with which they formed soluble complexes or to which they bind 
by primary interactions - possibilities that couldnot be detected by 
immunological techniques which depend on secondary interactions and 
formation of insoluble antibody-antigen complexes. 
14C-labelled N-acetylneuraminic acid* (20 µl) was added to each of 
the centrifuge tubes containing varying dilutions of antiserum(to fetuin 
or columnic acid) or control serum. The contents of each tube were 
mixed and incubated at 4o C for 3 hours. PBS was added to each tube to 
bring the final volume to 0.6 ml and after mixing, saturated ammonium 
sulphate (0.6 ml) was added; the contents of each tube were thoroughly 
mixed and allowed to stand for 20 minutes before centrifuging at 3000 xg 
for 15 minutes. The contents of each tube were completely transferred 
* N-acetyl [4,5,6,7,8,9-14C1 neuraminic acid commercially obtained 
(259 mCi/mmole) was diluted about 100-fold with the unlabelled N- 
acetylneuraminic acid. The working solution had a specific activity 
of 2150 cpm/µl . 
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and filtered over o fibreglass filter. The precipitates on the filters 
were washed with 50%, saturated ammonium sulphate solution (5.0 nil) 
and the filters were dried and their radioactivity content was determined 
by scintillation spectrometry (using Triton X-100 butyl PBD -cintillant). 
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Figure B. 4 [14C] NANA binding capacity of antiserum to colominic 
acid (---0-0-j and fetuin (--. -+-- ) determined by the 
Farr assay. Control serum (----k-'). 
(d) Equilibrium dialysis 
A microequilibrium dialysis apparatus similar to the one described 
by Neuhoff Kiehl [302](Figure B. 5) was used. This apparatus consisted 
of a number of pairs of small chambers, each capable of holding a 
volume of 0.8 ml. The chambers in each pair were separated by a dialysis 
membrane. 
Antibody immunoglobulins were prepared from the sera by 
precipitation with ammonium sulphate. Saturated ammonium sulphate 
--------ý_Y- -ý 01 100 50 25 12.5 6.25 3.125 1.56 
Dilution (1% serum) 
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(100% in distilled water) was added to a final concentration of 457, 
(v/v) to serum diluted 1: 1 with PBS. The mixture was stirred at room 
temperature for 30 minutes and centrifuged (2000 x g) for 15 min at 
40C. The precipitate was washed with 45% saturated ammonium 
sulphate three times by centrifugation. The precipitate was dissolved 
In a minimum volµme of PBS and exhaustively dialysed against PBS at 
40C. The protein concentration of the resulting solution was determined 
by its absorbance at 280 nmP assuming that an O. D. value of 1.0 (1 cm cuvette 
is equivalent to a gamma globulin concentration of 0.70 mg/ml ( 3011. 
Using this method, an average of 160 mg protein was olxaincd from 25 ml 
of serum. 
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Figure B. 5 Diairam of a microegluilihrium dialysis apparatus 
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A binding curve was obtained by studying the equilibration of 
constant amounts of antibody with various concentrations of 
14C_NANA 
on opposite sides of a dialysis membrane. For asingle pointof a 
binding curve, 3 compartments were set up. 
(1) The buffer control which was used to determine whether the 
equilibrium was established (Figure B. 6) and also the amount of 
14C-NANA 
adsorbed to the dialysis membrane and to the apparatus. 
(ii) An immunoglobulin fraction obtained from control serum which served 
to determine the amount of 
14C-NANAnon-specifically bound to immuno- 
globulins. 
(iii) A compartment containing the antibody solution to be tested (the 
immunoglobulin fraction prepared from the sera of fetuin-- or colominic - 
acid-injected rabbit, FAb and CAb respectively) with or vithout unlabelled 
NANA or other sugars to be tested. Against each of these was a 
compartment containing PBS (0.5 ml) referred to as the PBS-compartment. 
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Figure B. 6 Determination of completion of equilibrium. At the start 
of this experiment one compartment contained PBS (0.5 ml) and the other 
compartment contained 
14C-NANA (20 ; il) in 0.5 ml PBS. The equilibrium 
dialysis cell contained 12 such pairs of compartments and contents of each 
pair at a time at various time intervals were removed and their radioactivity 
content determined. PBS compartment sample compartment 
(-o--o -___ ). 
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To construct a binding curve (Figure B. 7)ß the radioactivity content 
In the antiserum compartment was determined after 60 hours of 
equilibration. 
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Figure B. 7 14C-NANA binding by FAb (-4-- )and CAb ( .. o.. o .) as 
determined byequilibriumdialysis. 14C-NANA solution (20 WI) was 
added in each of the compartments containing PBS or various dilutions of 
FAb, CAb or control serum. The values plotted were corrected for non- 
specific binding of 
14C-NANA by subtracting the counts of the PBS- 
compartment and of the corresponding dilution of control serum from the 
counts in the FAborCAb compartments. The dilutions were calculated, 
taking the 5mg/ml working solution of antibody solution as 100%. 
(e) Competition of 
14C-NANA 
and unlabelled NANA for CAb 
The antiserum to colominic acid showed a food dose -response curve 
in its binding of 
14C-NANA 
and appeared to bind more 
14C-NANA than 
did the antiserum to fetuin. The immunoglobullin fraction prepared from 
J, antibody concentration 
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colominic acidantiserumwas used to assess the possibility of using it 
In a competition assay of sto lic acid. Figure B. 8 shows the competition 
of varying amounts of unlabelled NANA against a constant amount of 
14C- 
NANA fur a constant amount of CAb' 
E 
n. 
z 
e z 
U 
ýr 
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Figure B. 8 Competition of 
14C-NANA 
and unlabelled NANA for CAb. 
The test compartments contained 
14C-NANA 
solution (20 µl), CAb 
(5 mg/ml in PBS, 0.5 ml) and varying amounts (0-100µg) of unlabelled 
NANA in 100µl PBS. The 
14C 
-NANA bound by CAb was determined as 
described earlier. 
Similar experiments were repeated, using N-acetylgalactosamine, 
N-acetylglucosamine, colominic acid, D-mannose, D-glucose or 
D-galactose instead of unlabelled NANA (Figure B. 9). 
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Figure B. 9 Competition of 
14C-NANA 
and other sugars for CAb. The 
test compartment contained 
14C-NANA 
solutions (20 µl)ß CAb (5 mg/ml in 
PBS, 0.5 m1) and the varying amounts of each of the sugars indicated: 
N-acetylgalactosamine ), N-acetylglucosamine (-r--+--- ) 
colom in is acid(-o----o--- ), D-mannose (-o - -o- -), D -glucose ý -A- ) 
ßt3---c1--) , and 
D -galactose 
(f) Attempts to purify CAb 
The Immunoglobulin fraction, CAb, was shown to bind to a column of 
protein-A Sepharose previously equilibrated with PBS. CAb was eluted by 
0.1 M glycine -hydrochloric acid buffer, pH 2.8. The eluted protein 
fractions were pooled and concentrated by Ultrafiltration through a PM 10 
membrane. The concentrated CAb fraction was then passed -through a 
0 25 50 75 100 
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column of starch -colominic acid, prepared as described by Uchida et al. 
[208] but equilibrated with PBS and eluted with 0.1 M glycine buffer, pH 
2.8. The eluted CAb protein fraction had the same properties as the 
serum obtained from colominic-acid-injected rabbits using the Immuno- 
logicaltechniques described above. 
DISCUSSION 
Contrary to previous reports that co? ominic acid lacks serological 
properties, the results of the present study suggest that wlen comominic 
acid is injected in rabbits, a component is produced in low concentration 
In serum which tightly binds 
14C-NANA 
as attested by the Farr assay 
and analysis, by equilibrium dialysis. However, other conventional 
techniques for antibody detection, ems, . immunodiffusion precipitation, 
failed to demonstrýFte such a componert. Since the component binds to 
protein-A, it is an immunoglobulin and since no similar component 
is detected in control serum, one could conclude that colominic acid 
is immunogenic In rabbits. The fact that immunoprecipitation 
techniques fall to detect the antibodies produced may relate to the 
nature of the cojnplexes formed between colominic acid and the anti- 
body molecules, Since Immunoglobulins contain sialic acid [303], it 
Is possible that secondary interactions, normally responsible for 
stabilis Eng antigen -antibody complexes, are prevented by repulsive 
interactions between the sialic acid moieties of the antibody molecules 
and those on colominic acid. The specificity of the CAb component is 
further demonstrated by its ability to bind on to a starch -colomirlic 
acid column, a property not shared by the control serum. 
For the purposes of radioimmunoassay for sialic acid, the good 
dose -response obtained with CAb would indicate its potential use. 
However, the rather high competition afforded by sugars such as N-acetyl - 
D-glucosamine, D-mannose and D-galactose in inhibiting the binding 
of 
14C-NANA 
to CAb is a big limitation for the practical application of 
this technique to assay sialic acid in biological samples. Other 
applications of antibodies to sialic acid such as labelling of cell surfaces, 
etc. would interest many who are researching on the biological 
importance of this sugar. 
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APPENDIX III 
Design of a longitudinal gel-slicer 
Disc electrophoresis on cylindrical gels is attractive to many 
investigators because of its sharp, well-defined separation boundaries 
which can be achieved with only minute quantities of sample. After 
successful separation of the sample components, it is often desirable 
to compare the area of enzymic (or other biochemical) activity with 
the corresponding protein (or other component) fraction. An additional 
sample is usually run for that purpose. Alternatively, the same sample 
gel stained for enzymic activity can, after appropriate washing, be 
subsequently stained for protein and the resulting colour quality is 
assessed for the presence of both enzyme and protein, if they contrast 
with other protein bands. 
However, it has often been necessary to obtain longitudinal sections 
of cylindrical gels after electrophoresis, which can then be treated 
differently and compared, because of several reasons, including: 
(a) attempt to avoid exposing the gel and sample components to the 
deleterious chemical reactions and other incompatible treatments 
associated with their localisation, (b) the need to correct for 
differences arising from dissimilarities in extents of gel-cross-linkage 
and actual gel dimensions, (c) sample and gelmaterial economy, (d) 
correction for artefacts introduced by differences in sample loading 
and separation, etc. The methods employed in obtaining longitudinal 
gel-slices have so far included slicing the gel with razors, scalpel or 
thin wire guided by the hand, all procedures which involve considerable 
handling problems and gel distortion. Some of these slicing methods 
Often require prior treatment, e. g. embedding or hardening of the gel. 
In this section, a simple device (Fig. C. 1) inexpensively designed to 
obtain identical longitudinal sections of cylindrical gels is described 
and Its advantages and applications are discussed. 
The device was constructed out of perspex and consists of a cylindrical 
shaft, E, of appropriate diameter, into which the gel-containing tube, D. 
fitted tightly when It was inserted. Before the gel tube was inserted, the 
I'? I. 
ýB 
rL ý ,ýp i 
E 
ý-- HH 
',, 
G 
eýý abc 
- 
Fig. C. 1 Longitudinal section of the 
slicer. o. ,b, c 
abc. Transverse section of 
cutting edges used to 
produce 2.3 and 4 
longitudinal sections 
respectively. 
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gel was loosened from the tube by carefully squirting water between the gel 
and the tube with a fine needle syringe [2181 to ensure free movement of the 
gel which is essential for accurate sectioning. The gel tube was then 
inserted until its bottom rested firmly on a horizontal, sharp thin blade, F. 
lyit: g across the diameter of the shaft and gel tube. A short section of 
rubber tubing, B, was attached at the free end of the gel tube, and filled 
with water; a 1$( equipped with an air valve (or a syringe), A, was attached 
on to the tubing as shown in Fig . C. 1. 
The gel moved down the tube smoothly by hydraulic transport when the 
bulb or syringe was squeezed gently and its lower end was smoothly sliced 
as it got forced onto the razor. The resultinggel slices, G, were 
conveniently collected in receivers, H, placed underneath the cutting blades. 
Theprecision, reproducibility and uniformity of slicing were checked by 
weighing and matching the slices from gels contained in ten tubes of 
approximately smlliardimensions, using polyacrylamide total gel 
concentrations in the range 3.5% - 20.0% and gel tube diameters of 0.3, 
0.4 and 0.5cm. 
DISCUSSION 
The development and improvements of transverse gel-slicers are 
commonly reported [ 304], but the problems of obtaining uniform longitudinal 
gel-sclices have often either been ignored or left to Individual practical 
solution and originality. The longitudinalgel -slicer described is simply 
constructed and simplifies slicing operations, affording rapidity and 
uniformity over a wide range of acrylamide concentrations. Its advantages 
Include sample economy, slicing directly from the electrophoresis tube 
without prior treatment of thegel, among others. The device can be ada., ted 
to slice gels from tubes of varying diameters and to produce more than two 
slices, as needed, by utilising the appropriate number of cutting edges (Fig. 
C. 1, a, b, c). 
Its applications include comparison of different functions of a component 
after electrophoresis to facilitate accurate identification of electrophoresis 
bands. This application was described in Chapter 2 when staining 
neuraminidase with protein or glycoprotein stains. The device is also useful 
for conveniently producing longitudinal slices that are required in various 
methods of detecting enzymes on gels after electrophoresls, e. g. the 
zymogram technique and other methods [305 1. 
123. 
APPENDIX IV 
Sources of materials 
N-acetylgalactosam[ne Sigma London 
, 
N-acetylglucosamine Sigma London 
, 
N-acetylneuramInic acid Sigma, London 
N -acetyl[ 4.5 61 7,81,9-14C] neuraminic acid The Radiochemical 9 Centre Amersham 
, 
ae-acid glycoprotein Scottish National Blood 
Transfusion Association 
Edinburgh 
Black K salt Koch Light Laboratories 
Buckinghamshire 
N-bromosuccinim[de Pierce and Warriner (UK) 
Ltd., Cheshire 
Carbonic anhydrase Sigma, London 
Carboxymethyl cellulose (MC) Whatman Ltd., Maidstone, 
Kent 
Colominic acid, sodium salt Sigma, London 
Cyanogen bromide Eastman Kodak Co., 
Rochester, N . Y. 
Dansyl amino acid standards Sigma, London 
Dansyl chloride Sigma, London 
Dansyl hydrazine Sigma, London 
DEAE -cellulose Whatman Ltd., Maidstone 
Kent 
Diethylpyrocarbonate Sigma, London 
5,5' -dithiob[s(2-nitrobenzoic )acid (DT NB) B. D. H. Chemicals Ltd., 
Poole, Dorset 
1-ethyl -3- (3 -dimethylaminopropyl )carbodiimide Sigma, London 
124. 
N-ethylmorpholine 
3H 
-glyc ine 
Glyc ine ethyl ester hydrochloride 
Hydroxylamine hydrochloride 
Hydroxylapatite 
B. D. H. Chemicals Ltd., 
Poole, Dorset 
The Radiochemical Centre, 
Amersham 
Sigma, London 
B. D. H. Chemicals Ltd., 
Poole, Dorset 
Bio-Rad Laboratories, Kent 
2, (S-methoxyphenyl)-cr1 -N-acetyl neuraminlc 
acid (MPN) ßoehringer, Mannheim 
Molecular weight markers B. D. H. Chemicals Ltd., 
Poole, Dorset 
Muc in Sigma, London 
Neuraminidase from Cl. perfringens London Sigma , 
4-pentanedlone (acetyl acetone) 2 B. D. F. Chemicals Ltd. , , Poole, Corset 
Phenylglyoxal Koch Light Laboratories 
Buck inghamshIre 
PM-10 membranes Amicon Corporation, 
Mass. Lexington U. S. A. 
, , 
Protein-A Sepharose Pharmacia Fine Chemicals, 
Sweden 
Rose Bengal B. D. H. Chemicals Ltd. 
, Dorset Poole 
, 
Sephadex G-25 Pharmacia Fine Chemicals, 
Sweden 
Sephadex G-100 Pharmacia Fine Chemicals, 
Sweden 
Sepharose 4B Pharmacia Fine Chemicals, 
Sweden 
Sialyllactose Sic, ma, London 
Sodium borohydride Hopkins and Williams, Essex 
Thiobarbituric acid Sigma, London 
2,4,6-trinitrobenzenesulphonic acid (TNBS) Sigma, London 
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